175 results on '"Afranio Lineu Kritski"'
Search Results
2. As redes vivas na produção do cuidado com o usuário na centralidade do tratamento para tuberculose multidroga resistente
- Author
-
Janaina Aparecida de Medeiros Leung, Fátima Teresinha Scarparo Cunha, Emerson Elias Merhy, and Afranio Lineu Kritski
- Subjects
Tuberculose ,Tuberculose multidroga resistente ,Cuidado centrado no paciente ,Acontecimentos que mudam a vida ,Redes comunitárias ,Public aspects of medicine ,RA1-1270 - Abstract
Vivenciamos a trajetória de uma usuária-guia no tratamento para tuberculose multidroga resistente (TB-MDR). As narrativas das redes vivas na produção de cuidado apontam para os seguintes itens: 1) cuidar no ato de viver: suplantar os estigmas e cultivar vínculos que ajudem a superar os discursos fomentados pelo medo, preconceitos, exclusão e invisibilidade dos sujeitos; 2) redes vivas de cuidado: os entremeios da norma; e 3) as interfaces de atenção usuário-trabalhador da saúde: como desmistificar o julgamento dos trabalhadores da saúde, que, subordinados a protocolos limitantes, muitas vezes estigmatizam o usuário como “abandonador de tratamento”?. A usuária-guia vislumbrou que cuidar é se desterritorializar, é colocar os desejos como potência para transformação, saindo do modus operandi rumo à criatividade, tendo o usuário no centro do processo.
- Published
- 2023
- Full Text
- View/download PDF
3. The role of mini-bronchoalveolar lavage fluid in the diagnosis of pulmonary tuberculosis in critically ill patients
- Author
-
Cynthia Pessoa Neves, Allyson Guimarães Costa, Izabella Picinin Safe, Alexandra de Souza Brito, Jaquelane Silva Jesus, Afranio Lineu Kritski, Marcus Vinicius Guimarães Lacerda, Miguel Viveiros, and Marcelo Cordeiro-Santos
- Subjects
Pulmonary tuberculosis ,Intensive care medicine ,Diagnosis ,Mini-BAL ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The detection of Mycobacterium tuberculosis (MTB) in the intensive care unit (ICU) presents several challenges, mainly associated to the clinical state of the patient. The presence of HIV infection further aggravates this scenario, requiring a reliable collection method, with better performance in the microbiological/molecular techniques to be used. We evaluated the performance of two methods for sample collection, mini bronchoalveolar lavage (Mini-BAL) and endotracheal aspirate (ETA), for diagnosis of pulmonary tuberculosis (PTB) in critically ill patients. Methods This prospective study involved 26 HIV positive ICU internalized patients, with presumptive PTB who required mechanical ventilation. Two samples were obtained prospectively from 26 HIV ICU patients with presumptive PTB by Mini-BAL and ETA. The samples were processed for smear microscopy, Löwenstein-Jensen medium and the BACTEC Mycobacteria Growth Indicator Tube 960 system®. We define as confirmed PTB patients with positive MTB culture. Furthermore, all samples obtained through the Mini-BAL were analyzed by Xpert® MTB/RIF. Results Our results demonstrated that the respiratory samples obtained by Mini-BAL were able to increase MTB detection in critically ill patients with presumptive PTB. The Mini-BAL allowed 30% increased recovery and guaranteed enough sample volume for processing in all methods. In addition, the larger volume of the samples obtained with this technique enabled the Xpert® MTB/RIF molecular test for diagnosis of TB. Conclusions The Mini-BAL showed be an acceptable alternative to ETA in this population, since these critically ill and often-immunocompromised patients are more likely to develop complications related to invasive procedures.
- Published
- 2020
- Full Text
- View/download PDF
4. String test: a potentially useful tool in the diagnosis of pulmonary tuberculosis in Brazilian children and adolescents
- Author
-
Claudete Aparecida Araújo Cardoso, Andrea Maciel de Oliveira Rossoni, Joana Moraes de Rezende, Rafaela Baroni Aurilio, Roberta Jaime Ferreira Lima dos Santos, Maria Aparecida Gadiani Ferrarini, Afranio Lineu Kritski, Anandi Martin, and Clemax Couto Sant’Anna
- Subjects
Diagnostic techniques and procedures ,Pulmonary tuberculosis ,Children ,String test ,Arctic medicine. Tropical medicine ,RC955-962 ,Infectious and parasitic diseases ,RC109-216 - Abstract
ABSTRACT This study investigated the potential use of the String Test (ST) for the diagnosis of pulmonary tuberculosis (PTB) in children and adolescents. This is a case series of patients aged 4-15 years presenting with clinically presumed PTB and submitted to ST in three pediatric TB referral centers in Brazil, between November 2017 and July 2020. The ST was performed in the morning, after 4-12 h of fasting, followed by ingestion of the capsule by the patient, which was attached to the patient’s malar region. The material was collected for simultaneous smear microscopy (acid-fast bacilli - AFB), culture and the molecular investigation by the GeneXpert MTB/RIF®. Thirty-three patients with presumed PTB were included and ST was performed in 26 (78.8%) of them and 7 (21.2%) patients could not swallow the cord. The diagnosis of PTB was established in 11 (42.3%) of the 26 patients who underwent the ST. The diagnosis of PTB was confirmed (by culture or GeneXpert MTB/RIF®) in 5 patients, 4 of whom were also positive by the ST. Two of them showed positivity by the GeneXpert MTB/RIF® only in the ST sample. Two other patients had a positive ST following the induced sputum test (AFB, GeneXpert MTB/RIF®, and positive culture in both specimens). Thus, ST was positive in 36.4% of the patients in whom PTB was diagnosed. ST could be a useful test for diagnosing PTB in children and adolescents.
- Published
- 2022
- Full Text
- View/download PDF
5. A screening system for smear-negative pulmonary tuberculosis using artificial neural networks
- Author
-
João B. de O. Souza Filho, José Manoel de Seixas, Rafael Galliez, Basilio de Bragança Pereira, Fernanda C. de Q Mello, Alcione Miranda dos Santos, and Afranio Lineu Kritski
- Subjects
Decision support systems ,Data mining ,Computational intelligence ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: Molecular tests show low sensitivity for smear-negative pulmonary tuberculosis (PTB). A screening and risk assessment system for smear-negative PTB using artificial neural networks (ANNs) based on patient signs and symptoms is proposed. Methods: The prognostic and risk assessment models exploit a multilayer perceptron (MLP) and inspired adaptive resonance theory (iART) network. Model development considered data from 136 patients with suspected smear-negative PTB in a general hospital. Results: MLP showed higher sensitivity (100%, 95% confidence interval (CI) 78–100%) than the other techniques, such as support vector machine (SVM) linear (86%; 95% CI 60–96%), multivariate logistic regression (MLR) (79%; 95% CI 53–93%), and classification and regression tree (CART) (71%; 95% CI 45–88%). MLR showed a slightly higher specificity (85%; 95% CI 59–96%) than MLP (80%; 95% CI 54–93%), SVM linear (75%, 95% CI 49–90%), and CART (65%; 95% CI 39–84%). In terms of the area under the receiver operating characteristic curve (AUC), the MLP model exhibited a higher value (0.918, 95% CI 0.824–1.000) than the SVM linear (0.796, 95% CI 0.651–0.970) and MLR (0.782, 95% CI 0.663–0.960) models. The significant signs and symptoms identified in risk groups are coherent with clinical practice. Conclusions: In settings with a high prevalence of smear-negative PTB, the system can be useful for screening and also to aid clinical practice in expediting complementary tests for higher risk patients.
- Published
- 2016
- Full Text
- View/download PDF
6. Anemia in hospitalized patients with pulmonary tuberculosis
- Author
-
Marina Gribel Oliveira, Karina Neves Delogo, Hedi Marinho de Melo Gomes de Oliveira, Antonio Ruffino-Netto, Afranio Lineu Kritski, and Martha Maria Oliveira
- Subjects
Tuberculose pulmonar ,Anemia ,Desnutrição ,Ferro ,Diseases of the respiratory system ,RC705-779 - Abstract
OBJECTIVE: To describe the prevalence of anemia and of its types in hospitalized patients with pulmonary tuberculosis. METHODS: This was a descriptive, longitudinal study involving pulmonary tuberculosis inpatients at one of two tuberculosis referral hospitals in the city of Rio de Janeiro, Brazil. We evaluated body mass index (BMI), triceps skinfold thickness (TST), arm muscle area (AMA), ESR, mean corpuscular volume, and red blood cell distribution width (RDW), as well as the levels of C-reactive protein, hemoglobin, transferrin, and ferritin. RESULTS: We included 166 patients, 126 (75.9%) of whom were male. The mean age was 39.0 ± 10.7 years. Not all data were available for all patients: 18.7% were HIV positive; 64.7% were alcoholic; the prevalences of anemia of chronic disease and iron deficiency anemia were, respectively, 75.9% and 2.4%; and 68.7% had low body weight (mean BMI = 18.21 kg/m2). On the basis of TST and AMA, 126 (78.7%) of 160 patients and 138 (87.9%) of 157 patients, respectively, were considered malnourished. Anemia was found to be associated with the following: male gender (p = 0.03); low weight (p = 0.0004); low mean corpuscular volume (p = 0.03);high RDW (p = 0; 0003); high ferritin (p = 0.0005); and high ESR (p = 0.004). We also found significant differences between anemic and non-anemic patients in terms of BMI (p = 0.04), DCT (p = 0.003), and ESR (p < 0.001). CONCLUSIONS: In this sample, high proportions of pulmonary tuberculosis patients were classified as underweight and malnourished, and there was a high prevalence of anemia of chronic disease. In addition, anemia was associated with high ESR and malnutrition.
- Published
- 2014
- Full Text
- View/download PDF
7. Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil
- Author
-
Vania Celina Dezoti Micheletti, José da Silva Moreira, Marta Osório Ribeiro, Afranio Lineu Kritski, and José Ueleres Braga
- Subjects
Tuberculose/diagnóstico ,Resistência a medicamentos ,HIV ,Diseases of the respiratory system ,RC705-779 - Abstract
OBJECTIVE: To describe the prevalence of multidrug-resistant tuberculosis (MDR-TB) among tuberculosis patients in a major Brazilian city, evaluated via the Second National Survey on Antituberculosis Drug Resistance, as well as the social, demographic, and clinical characteristics of those patients. METHODS: Clinical samples were collected from tuberculosis patients seen between 2006 to 2007 at three hospitals and five primary health care clinics participating in the survey in the city of Porto Alegre, Brazil. The samples were subjected to drug susceptibility testing. The species of mycobacteria was confirmed using biochemical methods. RESULTS: Of the 299 patients included, 221 (73.9%) were men and 77 (27.3%) had a history of tuberculosis. The mean age was 36 years. Of the 252 patients who underwent HIV testing, 66 (26.2%) tested positive. The prevalence of MDR-TB in the sample as a whole was 4.7% (95% CI: 2.3-7.1), whereas it was 2.2% (95% CI: 0.3-4.2) among the new cases of tuberculosis and 12.0% (95% CI: 4.5-19.5) among the patients with a history of tuberculosis treatment. The multivariate analysis showed that a history of tuberculosis and a longer time to diagnosis were both associated with MDR-TB. CONCLUSIONS: If our results are corroborated by other studies conducted in Brazil, a history of tuberculosis treatment and a longer time to diagnosis could be used as predictors of MDR-TB.
- Published
- 2014
- Full Text
- View/download PDF
8. Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis
- Author
-
Beatriz Lima Alezio Muller, Daniela Maria de Paula Ramalho, Paula Fernanda Gonçalves dos Santos, Eliene Denites Duarte Mesquita, Afranio Lineu Kritski, and Martha Maria Oliveira
- Subjects
Tuberculose ,Citocinas ,Sistema imunológico ,Polimorfismo de nucleotídeo único ,Diseases of the respiratory system ,RC705-779 - Abstract
OBJECTIVE: To describe serum levels of the cytokines IL-10, TNF-α, and IFN-γ, as well as polymorphisms in the genes involved in their transcription, and their association with markers of the acute inflammatory response in patients with pulmonary tuberculosis.METHODS: This was a descriptive, longitudinal study involving 81 patients with pulmonary tuberculosis treated at two referral hospitals. We collected data on sociodemographic variables and evaluated bacteriological conversion at the eighth week of antituberculosis treatment, gene polymorphisms related to the cytokines studied, and serum levels of those cytokines, as well as those of C-reactive protein (CRP). We also determined the ESR and CD4+ counts.RESULTS: The median age of the patients was 43 years; 67 patients (82.7%) were male; and 8 patients (9.9%) were infected with HIV. The ESR was highest in the patients with high IFN-γ levels and low IL-10 levels. IFN-γ and TNF-α gene polymorphisms at positions +874 and −238, respectively, showed no correlations with the corresponding cytokine serum levels. Low IL-10 levels were associated with IL-10 gene polymorphisms at positions −592 and −819 (but not −1082). There was a negative association between bacteriological conversion at the eighth week of treatment and CRP levels.CONCLUSIONS: Our results suggest that genetic markers and markers of acute inflammatory response are useful in predicting the response to antituberculosis treatment.
- Published
- 2013
- Full Text
- View/download PDF
9. Avaliação de um escore clínico para rastreamento de suspeitos de tuberculose pulmonar Evaluación de un escore para rastreo de sospechosos de tuberculosis pulmonar Assessment of a clinical score for screening suspected pulmonary tuberculosis cases
- Author
-
Cristiano Bel Alves de Castro, Paulo Albuquerque da Costa, Antonio Ruffino-Netto, Ethel Leonor Noia Maciel, and Afranio Lineu Kritski
- Subjects
Tuberculosis Pulmonar ,Diagnóstico Clínico ,Técnicas y Procedimientos Diagnósticos ,Triaje ,Sensibilidad y Especificidad ,Tuberculose Pulmonar ,Técnicas e Procedimentos Diagnósticos ,Triagem ,Sensibilidade e Especificidade ,Tuberculosis ,Clinical Diagnosis ,Diagnostic Techniques and Procedures ,Triage ,Sensitivity and Specificity ,Public aspects of medicine ,RA1-1270 - Abstract
OBJETIVO: Avaliar acurácia de escore clínico (sensibilidade) no diagnóstico presuntivo de tuberculose pulmonar em triagem. MÉTODOS: Estudo descritivo-analítico transversal com 1.365 pacientes atendidos no setor de pneumologia em Unidade Básica de Saúde de nível secundário da cidade do Rio de Janeiro, RJ, de 2006 a 2007. Os participantes responderam um questionário padronizado, aplicado por equipe de enfermagem, contendo informações referentes à idade, peso e sintomas clínicos. O resultado presuntivo do diagnóstico de tuberculose pulmonar foi obtido pela soma da pontuação dos dados coletados. Diagnóstico de tuberculose ativa baseou-se nos resultados bacteriológicos e na decisão médica. Foram calculados sensibilidade, especificidade, valores preditivos positivos e negativos para uma prevalência especificada, e intervalos de 95% de confiança para diversos pontos de corte do escore. O desempenho do escore foi avaliado pela curva receiver operating characteristic (ROC). RESULTADOS: Para o diagnóstico de tuberculose, tosse > 1 semana e > 3 semanas mostrou sensibilidade respectivamente de 88,2% (86,2;90,2) e de 61,1% (57,93;64,3), especificidade de 19,2% (16,6;21,8) e 51,3% (48,1;54,5). O escore clínico com 8 pontos mostrou uma sensibilidade de 83,13% (77,8;87,6), especificidade de 51,8% (48,5;55,1), valor preditivo positivo de 91,6% (90,0;83,2) e negativo 32,9% (30,1;35,7). CONCLUSÕES: Tosse (> 3 sem) apresentou baixa sensibilidade e especificidade. Escore clínico com elevada sensibilidade pode ser uma ferramenta alternativa na detecção de tuberculose pulmonar, pois, além de agilizar o atendimento do caso suspeito na unidade, permite padronizar a primeira abordagem pela enfermagem.OBJETIVO: Evaluar la exactitud de escore clínico (sensibilidad) en el diagnostico presuntivo de tuberculosis pulmonar en pesquisa. MÉTODOS: Estudio descriptivo-analítico transversal con 1.365 pacientes atendidos en el sector de pneumonologia en Unidad Básica de Salud de nivel secundario de la ciudad de Rio de Janeiro, Sureste de Brasil, de 2006 a 2007. Los participantes respondieron un cuestionario estandarizado, aplicado por equipo de enfermería, conteniendo informaciones referentes a la edad, peso y síntomas clínicos. El resultado presuntivo del diagnostico de tuberculosis pulmonar fue obtenido por la suma de puntuación de los datos colectados. Diagnostico de tuberculosis activa se basó en los resultados bacteriológicos y en la decisión medica. Se calcularon sensibilidad, especificidad, valores predictivos positivos negativos para una prevalencia especificada, e intervalos de 95% de confianza para diversos puntos de corte del escore. El desempeño del escore fue evaluado por la curva receiver operating characteristic (ROC). RESULTADOS: Para diagnostico de tuberculosis, tos > 1 semana y > 3 semanas mostró sensibilidad respectivamente de 88,2% (86,2;90,2) y de 61,1% (57,93;64,3), especificidad de 19,2% (16,6;21,8) y 51,3% (48,1;54,5). El escore clínico con 8 puntos mostró una sensibilidad de 83,13%(77,8;87,6), especificidad de 51,8% (48,5;55,1), valor predictivo positivo de 91,6% (90,0;83,2) negativo 32,9% (30,1;35,7). CONCLUSIONES: Tos (>3 sem) presentó baja sensibilidad y especificidad. Escore clínico con elevada sensibilidad puede ser una herramienta alternativa en la detección de tuberculosis pulmonar, pues además de agilizar la atención del caso sospechoso en la unidad, permite estandarizar el primer abordaje por la enfermera.OBJECTIVE: To assess the accuracy (sensitivity) of a clinical score for presumptive pulmonary tuberculosis cases during screening. METHODS: Descriptive cross-sectional study comprising 1,365 patients attending the department of lung diseases at a secondary care outpatient clinic in the city of Rio de Janeiro, Southeastern Brazil, during 2006 and 2007. All respondents answered a standardized questionnaire administered by the clinic's nursing staff. Information on age, weight and clinical symptoms were collected. The presumptive diagnosis of pulmonary tuberculosis was made by summing up the scores of the data collected. The diagnosis of active tuberculosis was based on bacteriological findings and medical criteria. There were estimated sensitivity, specificity, positive predictive value and negative predictive value for a set prevalence, and 95% confidence intervals for different score cutoffs. The score performance was assessed using the receiver operating characteristic (ROC) curve. RESULTS: For the diagnosis of tuberculosis, cough for more than one week and cough for more than three weeks showed a sensitivity of 88.2% (86.2, 90.2) and 61.1% (57.93, 64.3), specificity 19.2% (16.6, 21.8) and 51.3% (48.1, 54.5), respectively. The clinical score of 8 had a sensitivity of 83.13% (77.8, 87.6), specificity of 51.8% (48.5, 55.1), positive predictive value of 91.6% (90.0, 83.2) and negative predictive value of 32.9% (30.1, 35.7). CONCLUSIONS: Cough for more than three weeks showed low sensitivity and specificity. A highly sensitive clinical score can be an alternative tool for screening pulmonary tuberculosis as it allows early care of suspected cases and standard nursing care approach.
- Published
- 2011
10. Proposta de vigilância de óbitos por tuberculose em sistemas de informação
- Author
-
Lia Selig, Afranio Lineu Kritski, Angela Maria Cascão, José Ueleres Braga, Anete Trajman, and Regina Maria Guedes de Carvalho
- Subjects
Tuberculosis ,Notificación de Enfermedad ,Mortalidad Hospitalaria ,Registros de Mortalidad ,Sistemas de Información ,Vigilancia Epidemiológica ,Public aspects of medicine ,RA1-1270 - Abstract
OBJETIVO: Propor estratégia de vigilância de óbitos relacionados à tuberculose com base no Sistema de Informação de Mortalidade. MÉTODOS: Dados sobre os 55 óbitos relacionados à tuberculose, ocorridos em dois hospitais de grande porte do Rio de Janeiro entre setembro de 2005 e agosto de 2006, foram obtidos no Sistema de Informação de Mortalidade. Esses casos foram confrontados com os registros no Sistema de Informação de Agravos de Notificação (Sinan). O incremento no número de notificações e na completitude dos dados foi avaliado, bem como o tipo de entrada e desfecho no Sinan. RESULTADOS: Dos 55 óbitos, 28 estavam notificados no Sinan. O relacionamento dos sistemas possibilitou as seguintes correções: 27 casos novos notificados, 14 novas notificações realizadas pela unidade em que ocorreu o óbito e o encerramento de dez notificações. Isso representou incremento de 41 (28%) notificações às 144 realizadas pelos dois hospitais em 2006. Nove casos foram reclassificados da condição de tuberculose sem confirmação para tuberculose com confirmação diagnóstica, e cinco casos foram reclassificados de tuberculose para Aids como causa básica de morte. CONCLUSÕES: A vigilância de óbitos por tuberculose proposta permitiu aumentar a completitude dos sistemas de informação, diminuir a subnotificação e o número de casos não encerrados, supervisionar a vigilância epidemiológica das unidades e a qualidade do preenchimento das declarações de óbito, além de buscar contatos não avaliados pela equipe de saúde.
- Published
- 2010
- Full Text
- View/download PDF
11. Perfil epidemiológico de pacientes portadores de TB internados em um hospital de referência na cidade do Rio de Janeiro Epidemiological profile of hospitalized patients with TB at a referral hospital in the city of Rio de Janeiro, Brazil
- Author
-
Hedi Marinho de Melo Guedes de Oliveira, Rossana Coimbra Brito, Afranio Lineu Kritski, and Antonio Ruffino-Netto
- Subjects
Tuberculose ,Epidemiologia ,Hospitalização ,Tuberculosis ,Epidemiology ,Hospitalization ,Diseases of the respiratory system ,RC705-779 - Abstract
OBJETIVO: Analisar o perfil epidemiológico dos pacientes internados em um hospital especializado no tratamento da TB. MÉTODOS: Foi realizado estudo descritivo e retrospectivo dos prontuários dos pacientes internados com TB no Hospital Estadual Santa Maria (HESM), na cidade do Rio de Janeiro, entre janeiro de 2002 e dezembro de 2003, por meio de formulário previamente padronizado. RESULTADOS: Dos 451 pacientes incluídos, 313 (69,4%) foram referenciados para o HESM por unidades de saúde, e 302 (67,0%) eram do gênero masculino. A maioria dos pacientes tinha entre 30 e 59 anos, 443 (98,2%) residiam na região metropolitana, e 298 (66,1%) residiam no município do Rio de Janeiro. O motivo de internação mais frequente foi mau estado geral (em 237, 52,5%). A AIDS foi a comorbidade mais frequente (em 137, 30,4%). Os sinais e sintomas mais frequentes no momento da internação foram emagrecimento, febre e tosse produtiva. A baciloscopia foi positiva em 122 casos (71,0%) com tosse produtiva no momento da internação. Dos 212 pacientes que estavam em retratamento, 156 (73,6%) referiram abandono a tratamento anterior. Quanto ao desfecho, 297 (65,8%) foram encaminhados para centros municipais de saúde, 83 (18,4%) evoluíram para óbito, e 44 (9,8%) curaram. As altas indesejadas ocorreram em 27 (6,0%) dos casos. CONCLUSÕES: A provisão de hospitais especializados em TB é de relevância para o controle da TB, principalmente em regiões metropolitanas. Esses hospitais precisam estar adequados a medidas de biossegurança, assim como estar mais bem equipados e capacitados para prestar atendimento a pacientes com diversas comorbidades e problemas sociais associados à TB. A realização deste estudo resultou em melhorias para o HESM.OBJECTIVE: To determine the epidemiological profile of inpatients at a TB referral hospital. METHODS: This was a descriptive, retrospective study of the medical charts of patients with TB hospitalized at the Hospital Estadual Santa Maria (HESM), in the city of Rio de Janeiro, Brazil, between January of 2002 and December of 2003. Data were collected using a standardized form. RESULTS: Of the 451 patients included in the study, 313 (69.4%) had been referred to the HESM from health care clinics, and 302 (67.0%) were male. Most of the patients were in the 30-59 year age bracket, 443 (98.2%) lived in the greater metropolitan region of Rio de Janeiro, and 298 (66.1%) lived in the city of Rio de Janeiro itself. The most common reason for hospitalization was poor health status (in 237, 52.5%). The most common comorbidity was AIDS (in 137, 30.4%). The most common signs and symptoms at admission were weight loss, fever and productive cough. Sputum smear microscopy was positive in 122 (71.0%) of the patients presenting with productive cough at admission. Of the 212 patients being retreated, 156 (73.6%) reported noncompliance with previous treatment. Regarding the outcome, 273 (65.8%) of the patients were referred to municipal health care centers, 83 (18.4%) died, 44 (9.8%) were cured, and 27 (6%) were discharged against medical advice. CONCLUSIONS: Providing hospitals specializing in TB is relevant for TB control, especially in metropolitan regions. In addition to taking biosafety measures, these hospitals must be prepared to treat patients with TB-related comorbidities and social problems. This study has resulted in improvements at the HESM.
- Published
- 2009
- Full Text
- View/download PDF
12. Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study.
- Author
-
Anneliese Domingues Wysocki, Tereza Cristina Scatena Villa, Tiemi Arakawa, Maria Eugênia Firmino Brunello, Silvia Helena Figueiredo Vendramini, Aline Aparecida Monroe, and Afranio Lineu Kritski
- Subjects
Medicine ,Science - Abstract
BACKGROUND:Diagnosis and treatment of latent tuberculosis infection (LTBI) is a tool for global TB control, especially in close contacts. But data is scarce in high burden countries, under field conditions, including data on the benefits of LTBI management. OBJECTIVE:To analyze the LTBI diagnosis and treatment cascade among contacts in primary health care (PHC) services in São José do Rio Preto-SP, Brazil. METHODS:Cross-sectional design, conducted with contacts of pulmonary TB patients followed in all PHC services. Data was collected from May to September 2014 in the Reporting System for TB cases (TBWEB) and Reporting System for Chemoprophylaxis. Medical records and treatment follow-up forms were reviewed and all the nurses responsible for TB in PHC services were interviewed. RESULTS:Among 336 contacts included, 267 (79.4%) were screened for TB or LTBI, according to the presence or not of respiratory symptoms. Among those contacts screened, 140 (52.4%) were symptomatic, 9 (3.4%) had TB disease, 106/221 (48%) had positive TST result, meeting the criteria for LTBI treatment, and 64/106 (60.4%) actually started it. Overall, among 267 screened, only 64 (24%) started LTBI treatment. The completion rates of treatment among the contacts who started it, those with positive TST result and those screened were 56.3% (36/64), 16.3% (36/221) and 13.5% (36/267), respectively. Nurses claimed that asymptomatic TB contacts pay no attention to preventive health care and do not seek medical care as they do not have symptoms of the disease. In reviewing the medical records, high proportions of contacts without evaluation, incomplete assessment, incorrect records of contraindication for LTBI treatment, lack of notes regarding the identification and evaluation of contacts were identified. CONCLUSIONS:There is a need for better organization of the surveillance and investigation routine for contacts in PHC, considering the reorganization of the work process and the features of the local health system.
- Published
- 2016
- Full Text
- View/download PDF
13. Influência do tamanho do frasco de tuberculina nos resultados da prova tuberculínica Influence of vial size on the results of the tuberculin test
- Author
-
Antonio Ruffino-Netto, Afranio Lineu Kritski, Eleny Guimarães Teixeira, Carla Conceição dos Santos Loredo, Danielle Novelo de Souza, and Anete Trajman
- Subjects
Prova tuberculínica ,Tuberculina ,Frasco ,Adsorção ,PPD ,Mantoux ,Tuberculin Skin Test ,Tuberculin ,Adsorption ,Diseases of the respiratory system ,RC705-779 - Abstract
INTRODUÇÃO: A solução de tuberculina é armazenada em frascos de diferentes tamanhos. Sua adsorção ao frasco pode influenciar o resultado da prova tuberculínica. OBJETIVO: Avaliar o efeito do tamanho do frasco de armazenamento da tuberculina nos resultados obtidos na prova tuberculínica. MÉTODO: Sessenta e três pacientes internados com diagnóstico de tuberculose ativa foram submetidos a duas provas tuberculínicas simultâneas, em ambos os antebraços. A técnica usada foi a de Mantoux e consistiu na aplicação de 0,1 ml de tuberculina armazenada em frascos de 5 ml ou de 1,5 ml, no antebraço direito e no antebraço esquerdo, de forma aleatória. A leitura da induração foi efetuada de forma cega por um único leitor treinado previamente. As leituras com diferenças de até 2 mm foram consideradas resultados concordantes. RESULTADOS: Vinte e um pacientes não tiveram induração e foram excluídos da análise. Entre os 42 pacientes restantes, a média dos diâmetros das indurações obtidas nas provas com tuberculina armazenada nos frascos grandes foi maior do que as obtidas com a armazenada em frascos pequenos. A concordância entre as leituras foi obtida em 40,5% delas (17/42), e a diferença foi negativa (frasco grande menor que frasco pequeno) em 16,7% (7/42) e positiva em 42,9% delas (18/42). CONCLUSÃO: O tamanho do frasco de armazenamento da tuberculina pode influenciar o resultado da prova tuberculínica. A adsorção da tuberculina à parede do frasco pode explicar o fenômeno. Os autores alertam para o impacto dessas variações nos estudos epidemiológicos e operacionais.BACKGROUND: Tuberculin purified protein derivative is stored in vials of various sizes. Its adsorption to the vial can influence the results of tuberculin tests. OBJECTIVE: To evaluate the effect of vial size on the results obtained in tuberculin tests. METHODS: Sixty-four inpatients with active tuberculosis were submitted to two simultaneous tuberculin tests using the Mantoux technique. Patients were randomly allocated to receive two 0.1-ml injections, either one in the right forearm from a 1.5-ml vial and one in the left forearm from a 5-ml vial or vice versa. Induration was determined in a blinded fashion by a single, previously trained observer. Right arm-left arm differences of 2 mm or less were considered concordant results. RESULTS: Twenty-one patients presented no induration and were excluded from analysis. Among the 42 remaining patients, mean induration diameters obtained in tuberculin tests using the larger vials were greater than those obtained in tests using the smaller vials. Concordance was achieved in 40.5% (17/42). The difference was negative (large-vial indurations smaller than small-vial indurations) in 16.7% (7/42) and positive in 42.9% (18/42). CONCLUSIONS: The size of the vial may influence tuberculin test results. Adsorption to the sides of the vial may explain this phenomenon. The authors caution others to be aware of the impact of these variations in epidemiological and operational studies.
- Published
- 2005
- Full Text
- View/download PDF
14. Performance comparison between the mycobacteria growth indicator tube system and Löwenstein-Jensen medium in the routine detection of Mycobacterium tuberculosis at public health care facilities in Rio de Janeiro, Brazil: preliminary results of a pragmatic clinical trial
- Author
-
Adriana da Silva Rezende Moreira, Gisele Huf, Maria Armanda Vieira, Leila Fonseca, Monica Ricks, and Afranio Lineu Kritski
- Subjects
Ensaio clinico controlado ,Tuberculose ,Testes diagnosticos de rotina ,Diseases of the respiratory system ,RC705-779 - Abstract
In view of the fact that the World Health Organization has recommended the use of the mycobacteria growth indicator tube (MGIT) 960 system for the diagnosis of tuberculosis and that there is as yet no evidence regarding the clinical impact of its use in health care systems, we conducted a pragmatic clinical trial to evaluate the clinical performance and cost-effectiveness of the use of MGIT 960 at two health care facilities in the city of Rio de Janeiro, Brazil, where the incidence of tuberculosis is high. Here, we summarize the methodology and preliminary results of the trial. (ISRCTN.org Identifier: ISRCTN79888843 [http://isrctn.org/])
- Published
- 2013
- Full Text
- View/download PDF
15. Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil.
- Author
-
Adriana da Silva Rezende Moreira, Gisele Huf, Maria Armanda Monteiro da Silva Vieira, Paulo Albuquerque da Costa, Fábio Aguiar, Anna Grazia Marsico, Leila de Souza Fonseca, Mônica Ricks, Martha Maria Oliveira, Anne Detjen, Paula Isono Fujiwara, Stephen Bertel Squire, and Afranio Lineu Kritski
- Subjects
Medicine ,Science - Abstract
The use of liquid medium (MGIT960) for tuberculosis (TB) diagnosis was recommended by WHO in 2007. However, there has been no evaluation of its effectiveness on clinically important outcomes.A pragmatic trial was carried out in a tertiary hospital and a secondary health care unit in Rio de Janeiro City, Brazil. Participants were 16 years or older, suspected of having TB. They were excluded if only cerebral spinal fluid or blood specimens were available for analysis. MGIT960 technique was compared with the Lowenstein-Jensen (LJ) method for laboratory diagnosis of active TB. Primary outcome was the proportion of patients who had their initial medical management changed within 2 months after randomisation. Secondary outcomes were: mean time for changing the procedure, patient satisfaction with the overall treatment and adverse events. Data were analysed by intention-to-treat. Between April 2008 and September 2011, 693 patients were enrolled (348 to MGIT, 345 to LJ). Smear and culture results were positive for 10% and 15.7% of participants, respectively. Patients in the MGIT arm had their initial medical management changed more frequently than those in the LJ group (10.1% MGIT vs 3.8% LJ, RR 2.67 95% CI 1.44-.96, p = 0.002, NNT 16, 95% CI 10-39). Mean time for changing the initial procedure was greater in LJ group at both sites: 20.0 and 29.6 days in MGIT group and 52.2 and 64.3 in LJ group (MD 33.5, 95% CI 30.6-36.4, p = 0.0001). No other important differences were observed.This study suggests that opting for the MGIT960 system for TB diagnosis provides a promising case management model for improving the quality of care and control of TB.Controlled-Trials.com ISRCTN79888843.
- Published
- 2015
- Full Text
- View/download PDF
16. Inhibition of the polymerase chain reaction by sputum samples from tuberculosis patients after processing using a silica-guanidiniumthiocyanate DNA isolation procedure
- Author
-
Philip Suffys, Patricia Rosa Vanderborght, Patricia Barros dos Santos, Leticia Almeida Pinto Correa, Yolanda Bravin, and Afranio Lineu Kritski
- Subjects
PCR ,sputum ,tuberculosis ,silica-guanidiniumthiocyanate ,inhibition ,Microbiology ,QR1-502 ,Infectious and parasitic diseases ,RC109-216 - Abstract
With the objective to evaluate PCR-mediated detection of Mycobacterium tuberculosis DNA as a diagnostic procedure for diagnosis of tuberculosis in individuals attending ambulatory services in Primary Health Units of the City Tuberculosis Program in Rio de Janeiro, Brazil, their sputum samples were collected and treated with a DNA extraction procedure using silica-guanidiniumthiocyanate. This procedure has been described to be highly efficient for extraction of different kind of nucleic acids from bacteria and clinical samples. Upon comparing PCR results with the number of acid-fast bacilli, no direct relation was observed between the number of bacilli present in the sample and PCR positivity. Part of the processed samples was therefore spiked with pure DNA of M. tuberculosis and inhibition of the PCR reaction was verified in 22 out of 36 (61%) of the samples, demonstrating that the extraction procedure as originally described should not be used for PCR analysis of sputum samples.
- Published
- 2001
- Full Text
- View/download PDF
17. THE BODY OF THE TUBERCULOSIS CARRIER: CONFLICTS, DIFFICULTIES, AND REGULAR PROJECTS
- Author
-
Angela M.Fernandes da Silva Bittencourt, Fernanda Carvalho de Queiroz Mello, Nebia Maria Almeida de Figueredo, and Afranio Lineu Kritski
- Subjects
tuberculose ,corpo ,Medicine ,Nursing ,RT1-120 - Abstract
Objetivo: Este estudo trata de responder a seguinte questão de investigação: como é o dia-a-dia do doente que faz o tratamento de tuberculose no HUCFF? Os objetivos foram identificar como o doente enfrenta seu dia-a-dia e discutir esses enfrentamentos para a adesão ao tratamento, por meio da Terapia Ocupacional. Método: Esta investigação se baseou na análise de conteúdo de Bardin, método que se preocupa com os aspectos da realidade e com o universo de significados. Para responder as questões, realizou-se processo de exploração do material das dez entrevistas gravadas por meio da pré-análise dos dados. Resultados: Os indicadores de enfrentamentos foram obtidos a partir de 76 evocações e que após a exploração e tratamento dos dados, os mesmos foram categorizados em três categorias: 1ª enfrentar a doença e suas conseqüências no cotidiano do tratamento; 2ª enfrentar a doença e as emoções cotidianas do tratar e a 3ª enfrentar a doença com espiritualidade e fé. Conclusão Concluiu-se que existem diversos elementos vividos pelos pacientes, afetando seu corpo e que a Terapia Ocupacional propicia a adesão e o vínculo ao tratamento.
- Published
- 2010
18. Avaliação de um escore clínico para rastreamento de suspeitos de tuberculose pulmonar
- Author
-
Cristiano Bel Alves de Castro, Paulo Albuquerque da Costa, Antonio Ruffino-Netto, Ethel Leonor Noia Maciel, and Afranio Lineu Kritski
- Subjects
tuberculosis pulmonar ,diagnóstico clínico ,técnicas y procedimientos diagnósticos ,triaje ,sensibilidad y especificidad ,Public aspects of medicine ,RA1-1270 - Abstract
OBJETIVO: Avaliar acurácia de escore clínico (sensibilidade) no diagnóstico presuntivo de tuberculose pulmonar em triagem. MÉTODOS: Estudo descritivo-analítico transversal com 1.365 pacientes atendidos no setor de pneumologia em Unidade Básica de Saúde de nível secundário da cidade do Rio de Janeiro, RJ, de 2006 a 2007. Os participantes responderam um questionário padronizado, aplicado por equipe de enfermagem, contendo informações referentes à idade, peso e sintomas clínicos. O resultado presuntivo do diagnóstico de tuberculose pulmonar foi obtido pela soma da pontuação dos dados coletados. Diagnóstico de tuberculose ativa baseou-se nos resultados bacteriológicos e na decisão médica. Foram calculados sensibilidade, especificidade, valores preditivos positivos e negativos para uma prevalência especificada, e intervalos de 95% de confiança para diversos pontos de corte do escore. O desempenho do escore foi avaliado pela curva receiver operating characteristic (ROC). RESULTADOS: Para o diagnóstico de tuberculose, tosse > 1 semana e > 3 semanas mostrou sensibilidade respectivamente de 88,2% (86,2;90,2) e de 61,1% (57,93;64,3), especificidade de 19,2% (16,6;21,8) e 51,3% (48,1;54,5). O escore clínico com 8 pontos mostrou uma sensibilidade de 83,13% (77,8;87,6), especificidade de 51,8% (48,5;55,1), valor preditivo positivo de 91,6% (90,0;83,2) e negativo 32,9% (30,1;35,7). CONCLUSÕES: Tosse (> 3 sem) apresentou baixa sensibilidade e especificidade. Escore clínico com elevada sensibilidade pode ser uma ferramenta alternativa na detecção de tuberculose pulmonar, pois, além de agilizar o atendimento do caso suspeito na unidade, permite padronizar a primeira abordagem pela enfermagem.
19. Proposta de vigilância de óbitos por tuberculose em sistemas de informação
- Author
-
Lia Selig, Afranio Lineu Kritski, Angela Maria Cascão, José Ueleres Braga, Anete Trajman, and Regina Maria Guedes de Carvalho
- Subjects
tuberculose ,notificação de doenças ,mortalidade hospitalar ,registros de mortalidade ,sistemas de informação ,vigilância epidemiológica ,Public aspects of medicine ,RA1-1270 - Abstract
OBJETIVO: Propor estratégia de vigilância de óbitos relacionados à tuberculose com base no Sistema de Informação de Mortalidade. MÉTODOS: Dados sobre os 55 óbitos relacionados à tuberculose, ocorridos em dois hospitais de grande porte do Rio de Janeiro entre setembro de 2005 e agosto de 2006, foram obtidos no Sistema de Informação de Mortalidade. Esses casos foram confrontados com os registros no Sistema de Informação de Agravos de Notificação (Sinan). O incremento no número de notificações e na completitude dos dados foi avaliado, bem como o tipo de entrada e desfecho no Sinan. RESULTADOS: Dos 55 óbitos, 28 estavam notificados no Sinan. O relacionamento dos sistemas possibilitou as seguintes correções: 27 casos novos notificados, 14 novas notificações realizadas pela unidade em que ocorreu o óbito e o encerramento de dez notificações. Isso representou incremento de 41 (28%) notificações às 144 realizadas pelos dois hospitais em 2006. Nove casos foram reclassificados da condição de tuberculose sem confirmação para tuberculose com confirmação diagnóstica, e cinco casos foram reclassificados de tuberculose para Aids como causa básica de morte. CONCLUSÕES: A vigilância de óbitos por tuberculose proposta permitiu aumentar a completitude dos sistemas de informação, diminuir a subnotificação e o número de casos não encerrados, supervisionar a vigilância epidemiológica das unidades e a qualidade do preenchimento das declarações de óbito, além de buscar contatos não avaliados pela equipe de saúde.
20. Spirometry results after treatment for pulmonary tuberculosis: comparison between patients with and without previous lung disease: a multicenter study
- Author
-
Eliane Viana Mancuzo, Eduardo Martins Netto, Nara Sulmonett, Vanessa de Souza Viana, Júlio Croda, Afranio Lineu Kritski, Fernanda Carvalho de Queiroz Mello, Simone de Souza Elias Nihues, Karen Rosas Sodre Azevedo, and Silvana Spíndola de Miranda
- Subjects
Tuberculosis, pulmonary ,Respiratory function tests ,Airway obstruction/complications ,Diseases of the respiratory system ,RC705-779 - Abstract
ABSTRACT Objective: To compare patients with and without previous lung disease, in terms of the spirometry results after they had been treated for pulmonary tuberculosis (PTB) and cured, as well as to analyze risk factors related to functional severity. Methods: This was a cross-sectional, multicenter study conducted at four referral centers in Brazil. Patients were divided into two groups: those with a history of lung disease or smoking (LDS+ group); and those with no such history (LDS− group). Patients underwent spirometry (at least six months after being cured). Sociodemographic and clinical data were collected. Results: A total of 378 patients were included: 174 (46.1%) in the LDS+ group and 204 (53.9%) in the LDS− group. In the sample as a whole, 238 patients (62.7%) had spirometric changes. In the LDS+ group, there was a predominance of obstructive lung disease (in 33.3%), whereas restrictive lung disease predominated in the LDS− group (in 24.7%). Radiological changes were less common in the LDS− group than in the LDS+ group (p < 0.01), as were functional changes (p < 0.05). However, of the 140 (79.1%) LDS− group patients with a normal or minimally altered chest X-ray, 76 (54%) had functional changes (p < 0.01). The risk factors associated with functional severity in the LDS− group were degree of dyspnea (p = 0.03) and moderate or severe radiological changes (p = 0.01). Conclusions: Impaired pulmonary function is common after treatment for PTB, regardless of the history of lung disease or smoking. Spirometry should be suggested for patients who develop moderate/severe dyspnea or relevant radiological changes after treatment for PTB.
- Full Text
- View/download PDF
21. Stigma and art therapy with Brazilian leprosy patients
- Author
-
Maria de Lourdes Goncalves Fernandes, Alicia Regina Navarro de Souza, Maria Dias Torres Kenedi, Antonio José Ledo Alves da Cunha, Afranio Lineu Kritski, and Maria Kátia Gomes
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2022
- Full Text
- View/download PDF
22. Bedaquiline versus injectable containing regimens for rifampicin-resistant and multidrug-resistant tuberculosis in a reference center in Brazil – a real-world evidence study using a retrospective design
- Author
-
Ana Paula Santos, Cristóvão Jorge Benace Jr, Janaina Aparecida de Medeiros Leung, Afrânio Lineu Kritski, and Fernanda Carvalho de Queiroz Mello
- Subjects
Tuberculosis ,Bedaquiline ,Adverse events ,Microbiological conversion ,Treatment outcome ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Drug resistance (DR) is one of the several challenges to global tuberculosis (TB) control. The implementation of bedaquiline (BED) for DR-TB after more than 40 years was expected to improve treatment outcomes as well as microbiologic conversion and adverse events (AE) occurrence. Methods Retrospective cohort study based on secondary data of patients with rifampicin-resistant (RR) or multidrug-resistant (MDR) TB reported to the Outpatient Clinic of Mycobacterial Diseases of the Thorax Diseases Institute – Federal University of Rio de Janeiro - Brazil, between 2016 and 2023. We aimed to evaluate microbiologic conversion, AE and TB treatment outcomes and compare them according to the treatment regimen used for RR/MDR-TB patients under routine conditions [Injectable Containing Regimens (ICR) versus BED Containing Regimens (BCR)]. Logistic regression and survival analysis using Cox regression and Kaplan Meier curve were used for statistical analysis. Results Of the 463 DR-TB patients notified during the study period, 297 (64.1%) were included for analysis (ICR = 197 and BCR = 100). Overall AEs were more frequent (83.7 vs. 16.3%, p
- Published
- 2024
- Full Text
- View/download PDF
23. Operational modeling for testing diagnostic tools impact on tuberculosis diagnostic cascade: A model design
- Author
-
Filipe Andrade Bernardi, Afranio Lineu Kritski, Tiago Lara Michelin Sanches, Luana Antunes Costa, Rafael Mello Galliez, and Domingos Alves
- Subjects
Tuberculosis ,biology ,Computer science ,Isoniazid ,020206 networking & telecommunications ,02 engineering and technology ,Molecular Technique ,Diagnostic tools ,biology.organism_classification ,medicine.disease ,Mycobacterium tuberculosis ,Risk analysis (engineering) ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,General Earth and Planetary Sciences ,020201 artificial intelligence & image processing ,Tuberculosis control ,Rifampicin ,General Environmental Science ,medicine.drug - Abstract
Line Probe Assay (LPA) is a rapid molecular technique used for the diagnosis of Mycobacterium Tuberculosis (MTB) presence and resistance to first-line drugs such as Rifampicin and Isoniazid. The study presented here is part of an initiative of the Brazilian Tuberculosis Network (REDE-TB) researchers, together with the National Brazilian Tuberculosis Control Program from Health Ministry for the development of mechanisms that improve the clinical and epidemiological impact of LPA use in reference centers in Brazil. Here we use the operational model concept to see sharply the whole flow of processes in order to evaluate diagnostics cascades. Based on that, first, we developed a design of tuberculosis system operations in discrete-time based model, then we made a description of an agent-based transmission model developed to be incorporated to the operational design. After the implementation of the design, we can make a prediction that directly influences the choice of the most appropriate intervention and consequently the result of the cost-effectiveness analysis, translated by the feasibility of the chosen test to future works.
- Published
- 2021
- Full Text
- View/download PDF
24. Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
- Author
-
Afranio Lineu Kritski, Márcia Pinto, Ricardo E. Steffen, and Anete Trajman
- Subjects
0301 basic medicine ,Adult ,Male ,Tuberculosis ,Adolescent ,Cost effectiveness ,Science ,MEDLINE ,Human immunodeficiency virus (HIV) ,Pharmacy ,HIV Infections ,medicine.disease_cause ,Article ,Mycobacterium tuberculosis ,03 medical and health sciences ,0302 clinical medicine ,Latent Tuberculosis ,Environmental health ,medicine ,Humans ,030212 general & internal medicine ,Cause of death ,Multidisciplinary ,biology ,Latent tuberculosis ,business.industry ,Middle Aged ,Health care economics ,medicine.disease ,biology.organism_classification ,bacterial infections and mycoses ,030104 developmental biology ,Costs and Cost Analysis ,HIV-1 ,Infectious diseases ,Medicine ,Female ,business ,Brazil - Abstract
Tuberculosis is the leading cause of death among people living with HIV (PLH). Preventive tuberculosis therapy reduces mortality in PLH, especially in those with a positive tuberculin skin test (TST). New, more specific technologies for detecting latent tuberculosis infection (LTBI) are now commercially available. We sought to analyse the cost-effectiveness of four different strategies for the diagnosis of LTBI in PLH in Brazil, from the Brazilian public health care system perspective. We developed a Markov state-transition model comparing four strategies for the diagnosis of LTBI over 20 years. The strategies consisted of TST with the currently used protein purified derivative (PPD RT 23), two novel skin tests using recombinant allergens (Diaskintest [Generium Pharmaceutical, Moscow, Russia] and EC [Zhifei Longcom Biologic Pharmacy Co., Anhui, China]), and the QuantiFERON-TB-Gold-Plus (Qiagen, Hilden, Germany). The main outcome was cost (in 2020 US dollars) per quality-adjusted life years (QALY). For the base case scenario, the Diaskintest was dominant over all other examined strategies. The cost saving estimate per QALY was US $1375. In sensitivity analyses, the Diaskintest and other newer tests remained cost-saving compared to TST. For PLH, TST could be replaced by more specific tests in Brazil, considering the current national recommendations.
- Published
- 2020
25. The role of mini-bronchoalveolar lavage fluid in the diagnosis of pulmonary tuberculosis in critically ill patients
- Author
-
Jaquelane Silva Jesus, Marcelo Cordeiro-Santos, Cynthia Pessoa Neves, Miguel Viveiros, Marcus V. G. Lacerda, Afranio Lineu Kritski, Alexandra Brito, Izabella Picinin Safe, and Allyson Guimarães Costa
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Critical Illness ,Population ,HIV Infections ,Mini-BAL ,law.invention ,Specimen Handling ,lcsh:Infectious and parasitic diseases ,Mycobacterium tuberculosis ,03 medical and health sciences ,0302 clinical medicine ,Medical microbiology ,law ,Internal medicine ,Diagnosis ,medicine ,Humans ,Mycobacteria growth indicator tube ,Intensive care medicine ,lcsh:RC109-216 ,Prospective Studies ,education ,Prospective cohort study ,Tuberculosis, Pulmonary ,Mechanical ventilation ,education.field_of_study ,biology ,business.industry ,Pulmonary tuberculosis ,030208 emergency & critical care medicine ,Middle Aged ,respiratory system ,biology.organism_classification ,Intensive care unit ,Respiration, Artificial ,Intensive Care Units ,Infectious Diseases ,030228 respiratory system ,Female ,Sample collection ,business ,Bronchoalveolar Lavage Fluid ,Research Article - Abstract
Background The detection of Mycobacterium tuberculosis (MTB) in the intensive care unit (ICU) presents several challenges, mainly associated to the clinical state of the patient. The presence of HIV infection further aggravates this scenario, requiring a reliable collection method, with better performance in the microbiological/molecular techniques to be used. We evaluated the performance of two methods for sample collection, mini bronchoalveolar lavage (Mini-BAL) and endotracheal aspirate (ETA), for diagnosis of pulmonary tuberculosis (PTB) in critically ill patients. Methods This prospective study involved 26 HIV positive ICU internalized patients, with presumptive PTB who required mechanical ventilation. Two samples were obtained prospectively from 26 HIV ICU patients with presumptive PTB by Mini-BAL and ETA. The samples were processed for smear microscopy, Löwenstein-Jensen medium and the BACTEC Mycobacteria Growth Indicator Tube 960 system®. We define as confirmed PTB patients with positive MTB culture. Furthermore, all samples obtained through the Mini-BAL were analyzed by Xpert® MTB/RIF. Results Our results demonstrated that the respiratory samples obtained by Mini-BAL were able to increase MTB detection in critically ill patients with presumptive PTB. The Mini-BAL allowed 30% increased recovery and guaranteed enough sample volume for processing in all methods. In addition, the larger volume of the samples obtained with this technique enabled the Xpert® MTB/RIF molecular test for diagnosis of TB. Conclusions The Mini-BAL showed be an acceptable alternative to ETA in this population, since these critically ill and often-immunocompromised patients are more likely to develop complications related to invasive procedures.
- Published
- 2020
- Full Text
- View/download PDF
26. Vascular endothelial growth factor (VEGF) and interleukin-1 receptor antagonist (IL-1Ra) as promising biomarkers for distinguishing active from latent tuberculosis in children and adolescents
- Author
-
Camila de Paula Martins, Fabiana Rabe Carvalho, Renan Faustino, Thalia Medeiros, Natalia Fonseca do Rosário, Christiane Mello Schmidt, Ana Paula Barbosa, Ana Paula Quintanilha dos Santos, Caio Pluvier Duarte Costa, Hugo Henrique Kegler dos Santos, Karina Yuriko Yaginuma, Elisangela Costa da Silva, Afranio Lineu Kritski, Clemax Couto Sant’Anna, Claudete Aparecida Araújo Cardoso, and Andrea Alice Silva
- Subjects
Microbiology (medical) ,Vascular Endothelial Growth Factor A ,Adolescent ,Vascular Endothelial Growth Factors ,Immunology ,Receptors, Interleukin-1 ,Mycobacterium tuberculosis ,Microbiology ,Interleukin 1 Receptor Antagonist Protein ,Infectious Diseases ,Cross-Sectional Studies ,Latent Tuberculosis ,Child, Preschool ,Humans ,Child ,Biomarkers - Abstract
Since distinguishing pulmonary (PTB) from latent tuberculosis (LTBI) in pediatric patients remains a challenge, we aimed to investigate the efficacy of immune mediators in diagnosing PTB and LTBI in this population. In this cross-sectional study performed with children and adolescents, serum levels of 20 biomarkers were assessed and data were analyzed according to age groups. We included 65 participants (PTB, n = 28 and LTBI, n = 37). Overall, levels of TNF-α, IL-1Ra, IL-6, IL-17A, VEGF, MMP-1, and procalcitonin were significantly higher (P 0.05) in adolescents and children10 years-old with PTB. Also, principal component analysis (PCA) showed that immune mediators were able to distinguish PTB from LTBI. VEGF and IL-1Ra presented the highest area under the curve (AUC) values, both separately (AUC 0.890 and 0.785) and combined (AUC 0.99). Taken together, we showed that VEGF and IL-1Ra are promising biomarkers to distinguish PTB from LTBI in pediatric patients, especially in children5 years-old.
- Published
- 2022
27. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil
- Author
-
Aline Benjamin, Alice M S Andrade, Elisangela C. Silva, Marina C. Figueiredo, Betina Durovni, Valeria Cavalcanti Rolla, Adriano Gomes-Silva, Marcelo Cordeiro-Santos, María B. Arriaga, Hiochelson Najibe Santos Ibiapina, Bruno B. Andrade, Alexandra B. Souza, Jamile G. de Oliveira, Brenda K. S. Carvalho, Renata Spener-Gomes, Mariana Araújo-Pereira, Afranio Lineu Kritski, Adriana S. R. Moreira, Allyson Guimarães Costa, Michael S. Rocha, Timothy R. Sterling, Megan Turner, and Solange Cavalcante
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,Physiology ,Interferon gamma release assay ,Tuberculin ,Enzyme-Linked Immunosorbent Assay ,Microbiology ,Specimen Handling ,Cohort Studies ,Technical support ,QuantiFERON-Plus ,Latent Tuberculosis ,Genetics ,medicine ,Humans ,Mass Screening ,Medical physics ,Prospective Studies ,quality control ,Protocol (science) ,IGRA ,General Immunology and Microbiology ,Ecology ,Latent tuberculosis ,business.industry ,screening ,Reproducibility of Results ,Cell Biology ,Mycobacterium tuberculosis ,medicine.disease ,bacterial infections and mycoses ,LTBI ,QR1-502 ,Infectious Diseases ,tuberculosis ,Observational study ,business ,Brazil ,Interferon-gamma Release Tests ,Cohort study ,Research Article - Abstract
The interferon gamma release assay (IGRA) has emerged as a useful tool for identifying latent tuberculosis infection (LTBI). This assay can be performed through testing platforms such as the QuantiFERON-TB Gold Plus (QFT-Plus) assay. This in vitro test has been incorporated into several guidelines worldwide and has recently been considered by the World Health Organization (WHO) for the diagnosis of LTBI. The possibility of systematically implementing IGRAs such as the QFT-Plus assay in centers that perform LTBI screening has been accelerated by the decreased availability of the tuberculin skin test (TST) in several countries. Nevertheless, the process to implement IGRA testing in routine clinical care has many gaps. The study utilized the expertise acquired by the laboratory teams of the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil consortium during study protocol implementation of LTBI screening of tuberculosis (TB) close contacts. RePORT-Brazil includes clinical research sites from Brazilian cities and is the largest multicenter cohort of TB close contacts in the country to date. Operational and logistical challenges faced during IGRA implementation in all study laboratories are described, as well as the solutions that were developed and led to the successful establishment of IGRA testing in RePORT-Brazil. The descriptions of the problems identified and resolved in this study can assist laboratories implementing IGRAs, in addition to manufacturers of IGRAs providing effective technical support. This will facilitate the implementation of IGRA testing in countries with large TB burdens, such as Brazil. IMPORTANCE The IGRA has emerged as a useful tool for identifying persons with LTBI. Although the implementation of IGRAs is of utmost importance, to our knowledge there is scarce information on the identification of logistical and technical challenges for systematic screening for LTBI on a large scale. Thus, the descriptions of the problems identified and resolved in this study can assist laboratories implementing IGRAs, in addition to manufacturers of IGRAs providing effective technical support. This will facilitate the implementation of IGRA testing in countries with large TB burdens, such as Brazil.
- Published
- 2021
- Full Text
- View/download PDF
28. Lessons learned from implementation of interferon-gamma release assay to screen for latent tuberculosis infection in a large multicenter observational cohort study in Brazil
- Author
-
Marina C. Figueiredo, Allyson Guimarães Costa, Aline Benjamin, María B. Arriaga, Adriano Gomes-Silva, Mariana Araújo-Pereira, Valeria Cavalcanti Rolla, Renata Spener-Gomes, Brenda K. S. Carvalho, Elisangela C. Silva, Timothy R. Sterling, Hiochelson Najibe Santos Ibiapina, Solange Cavalcante, Alice M S Andrade, Marcelo Cordeiro-Santos, Michael S. Rocha, Megan Turner, Afranio Lineu Kritski, Alexandra B. Souza, Adriana S. R. Moreira, Bruno B. Andrade, Betina Durovni, and Jamile G. de Oliveira
- Subjects
Protocol (science) ,medicine.medical_specialty ,Tuberculosis ,Latent tuberculosis ,business.industry ,Interferon gamma release assay ,Tuberculin ,medicine.disease ,Technical support ,medicine ,Observational study ,business ,Intensive care medicine ,Cohort study - Abstract
BackgroundInterferon-gamma release assay (IGRA) has emerged as a useful tool in identifying latent tuberculosis infection (LTBI). This assay can be performed through testing platforms, such as QuantiFERON-TB Gold Plus (QFT®-Plus). This in vitro test has been incorporated by several guidelines worldwide and has recently been considered for the diagnosis of LTBI by the World Health Organization (WHO). The possibility of systematically implementing IGRAs such as QFT®-Plus in centers that perform LTBI screening has been accelerated by the decreased availability of tuberculin skin testing (TST) in several countries. Nevertheless, the process to implement IGRA testing in routine clinical care has many gaps.MethodsThe study utilized the expertise acquired by the laboratory teams of the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil consortium during study protocol implementation of LTBI screening of TB close contacts.ResultsRePORT-Brazil includes clinical research sites from Brazilian cities and is the largest multicenter cohort of TB close contacts to date in the country. Operational and logistical challenges faced during IGRA implementation in all four study laboratories are described, as well as the solutions that were developed and led to the successful establishment of IGRA testing in RePORT-Brazil.ConclusionsThe problems identified and resolved in this study can assist laboratories implementing IGRAs, in addition to manufacturers of IGRAs providing effective technical support. This will facilitate the implementation of IGRA testing in countries with a high TB burden, such as Brazil.ImportanceThe interferon-gamma release assay (IGRA) has emerged as a useful tool in identifying persons with latent tuberculosis infection (LTBI). Although the implementation of IGRAs is of utmost importance, to our knowledge, there is scarce information on identification of logistical and technical challenges of systematic screening of for LTBI on a large scale. Thus, the problems identified and resolved in this study can assist laboratories implementing IGRAs, in addition to manufacturers of IGRAs providing effective technical support. This will facilitate the implementation of IGRA testing in countries with a high TB burden, such as Brazil.
- Published
- 2021
- Full Text
- View/download PDF
29. Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000–2014
- Author
-
Raquel Duarte, Afranio Lineu Kritski, Marcela Bhering, and Carla Nunes
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Tuberculosis ,Adolescent ,Antitubercular Agents ,Emigrants and Immigrants ,Logistic regression ,Odds ,Young Adult ,Sex Factors ,Pharmacotherapy ,Risk Factors ,Internal medicine ,Tuberculosis, Multidrug-Resistant ,Humans ,Medicine ,Treatment Failure ,Young adult ,Lost to follow-up ,Child ,Aged ,Aged, 80 and over ,Portugal ,business.industry ,Incidence ,Incidence (epidemiology) ,Middle Aged ,medicine.disease ,Multiple drug resistance ,Treatment Outcome ,Infectious Diseases ,Female ,Lost to Follow-Up ,business - Abstract
SETTING: The incidence of tuberculosis (TB) has been decreasing in Portugal. Lisbon concentrates the largest number of cases of multidrug-resistant (MDR) TB in the country. This study aims at identifying clinical and demographic factors associated with unfavourable treatment results of patients with MDR-TB in the city.METHOD: The data on 265 MDR-TB cases, notified from 2000 to 2014 in the District of Lisbon, were collected from the Tuberculosis Surveillance System. Unfavourable cases were classified as failure, loss to follow-up (LTFU) and death. Bivariate and multivariate logistic regressions were undertaken to estimate the factors associated with unfavourable outcomes, LTFU and death.RESULTS: The proportion of unfavourable outcomes was 30.5%. These were associated mostly with being male, foreign-born and resistant to kanamycin. Death was associated with being human immunodeficiency virus-positive and resistant to kanamycin. Being foreign-born had a 4.46-fold higher odds of a LTFU outcome than did being Portuguese-born. The foreign-born patients were mostly African immigrants.CONCLUSION: The main finding in this study is that foreign-born patients are associated with a higher probability of unfavourable outcomes than Portuguese-born patients. Therefore, foreign-born patients need more careful monitoring in the control of MDR-TB.
- Published
- 2019
- Full Text
- View/download PDF
30. Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil
- Author
-
Clemax Couto Sant'Anna, Afranio Lineu Kritski, E. C. C. Soares, Márcia Cortez Bellotti de Oliveira, and Ronir Raggio Luiz
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Care process ,medicine.medical_specialty ,Tuberculosis ,Adolescent ,030231 tropical medicine ,Treatment outcome ,HIV Infections ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Child ,Tuberculosis, Pulmonary ,Retrospective Studies ,business.industry ,Extrapulmonary tuberculosis ,Sputum ,Retrospective cohort study ,medicine.disease ,Infectious Diseases ,Molecular Diagnostic Techniques ,Clinical diagnosis ,Female ,Sample collection ,medicine.symptom ,business ,Brazil - Abstract
SETTING: Rio de Janeiro, RJ, Brazil, a high tuberculosis (TB) burden city.OBJECTIVE: To compare the sociodemographics, clinical characteristics, care process indicators (CPIs) and treatment outcomes among adolescents with pulmonary TB (PTB) and those with PTB + extrapulmonary TB (EPTB), who underwent testing with Xpert® and sputum culture.DESIGN: This was a retrospective study of data from three national databases from 2014 to 2016 of adolescents (aged 10–18 years) residing and notified in Rio de Janeiro City. Three groups were identified according to their Xpert and culture results: Group 1, Xpert- and culture-positive; Group 2, Xpert-positive and culture-negative; and Group 3, Xpert- and culture-negative. Study CPIs were as follows: the time between ‘sample collection and Xpert result release', ‘sample collection and treatment initiation' and ‘notification and treatment outcome'.RESULTS: Of 258 adolescents included in the study, 223 (86.4%) were in Group 1, 20 (7.8%) in Group 2 and 15 (5.8%) in Group 3. Groups 1 and 2 had a similar profile. Compared to Group 1, Group 3 had a higher proportion of HIV-positive cases (21.4% vs. 3.0%, P = 0.016), adolescents with a hospital diagnosis (53.3% vs. 7.6%, P < 0.001), and PTB + EPTB cases (20% vs. 0.4%; P < 0.001). There were no statistically significant differences in CPIs or treatment outcomes.CONCLUSION: The clinical diagnosis was decisive in more critical or complex patients, despite Xpert-negative results.
- Published
- 2019
- Full Text
- View/download PDF
31. Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries
- Author
-
Ana Júlia Reis, Igor Mokrousov, Diana Machado, Ana Bárbara Scholante Silva, Nuno Taveira, Fernando Maltez, Jaciara Diniz, Hugo Silva, David Couvin, Pedro Eduardo Almeida da Silva, Taane G. Clark, Leonardo Esteves, Elis R. Dalla-Costa, Amabelia Rodrigues, Paulo Rabna, Afranio Lineu Kritski, Fernanda Abilleira, José Roberto Lapa e Silva, Ruth McNerney, Arnab Pain, João Luis Rheingantz Scaini, Maíra Macedo, Rita Macedo, Luísa Jordão, Clarice Brum, Elizabeth Coelho, Isabel Couto, Nalin Rastogi, Sofia Viegas, Isabel Portugal, Maria Lucia Rosa Rossetti, Jorge Ramos, Carla Silva, João Perdigão, Sofia Clemente, Catarina Pereira, Andrea von Groll, Miguel Viveiros, Faculdade de Farmácia da Universidade de Lisboa, Universidade Federal do Rio Grande (FURG), Universidade Nova de Lisboa = NOVA University Lisbon (NOVA), Centro de Desenvolvimento Científico e Tecnológico [Porto Alegre] (CDCT), Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA), Hospital Curry Cabral [Lisbon, Portugal], Hospital da Divina Providência [Luanda], Ministry of Health [Mozambique], Institut national de santé publique [Bisseau], Instituto Superior de Ciências da Saúde Egas Moniz [Portugal], Federal University of Rio de Janeiro, Institute of Thoracic Diseases, Laboratory of Molecular Epidemiology and Evolutionary Genetics [St. Petersburg, Russia], Institut Pasteur de Saint-Pétersbourg, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Unité de la Tuberculose et des Mycobactéries - WHO Supranational TB Reference Laboratory, Institut Pasteur de la Guadeloupe, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), King Abdullah University of Science and Technology (KAUST), University of Cape Town, London School of Hygiene and Tropical Medicine (LSHTM), Universidade Luterana do Brasil (ULBRA), Financial support was provided by the European Society of Clinical Microbiology and Infectious Diseases, for which we would like to would like to acknowledge the Study Group for Mycobacterial Infections, Fundação CAPES [PVE-CAPES. 88881.064961/2014-01- Jose R. Lapa e Silva/UFRJ coordinator], Genotyping and susceptibility profile of Mycobacterium tuberculosis clinical isolates from Rio Grande, Brazil were funded by Apoio a Projetos de Pesquisa em Doenças Negligenciadas, Brazil/MCTI/CNPq/MS-SCTIE – Decit [404081/2012-6] and by Programa Pesquisa para o SUS – PPSUS - FAPERGS/MS/CNPq/SESRS [1193-2551/13-6], MIRU-VNTR typing and spoligotyping of Mycobacterium tuberculosis clinical isolates from Porto Alegre, Brazil were funded by National Council of Research [CNPq/MCTI/Universal - Project number: 441499/2014-7], Fundação para a Ciência e a Tecnologia (FCT) Portugal [PTDC/SAU-EPI/122400/2010], part of the EDCTP2 program supported by the European Union, Fundação Calouste Gulbenkian, Portugal [Project ref. P-99934]. JP was supported by a post doc fellowship from project [PTDC/SAU-EPI/122400/2010] and by fellowship [SFRH/BPD/95406/2013] from FCT. The phylogenetic analysis work at Nalin Rastogi's lab was supported by a FEDER grant financed by the European Union and Guadeloupe Region (Programme Opérationnel FEDER-Guadeloupe-Conseil Régional 2014-2020, Grant number 2015-FED-192). IM was supported by Russian Science Foundation (grant 14-14-00292). AP was supported by a faculty baseline funding from KAUST [BAS/1/1020-01-01]. DM was supported by FCT fellowship [SFRH/BPD/100688/2014] and DM, IC MV are thankful to [GHTM UID/Multi/04413/20139] from FCT and to projects 'ForDILAB-TB' and 'A implementação de um novo método de identificação rápida do complexo M. tuberculosis nos Laboratórios de Referência da Tuberculose de Maputo e Beira' from Fundação Calouste Gulbenkian and the Community of the Portuguese Speaking Countries (CPLP). CS was supported by FCT [SFRH/BD/73579/2010]. TC is funded by the Medical Research Council UK (Grant no. MR/K000551/1 and MR/M01360X/1, MR/N010469/1, MC_PC_15103)., European Project: 2015-FED-192,FEDER-Guadeloupe, and Universidade de Lisboa = University of Lisbon (ULISBOA)
- Subjects
Infecções Respiratórias ,0301 basic medicine ,Latin Americans ,Minisatellite Repeats ,MIRU-VNTR ,Databases, Genetic ,Tuberculosis, Multidrug-Resistant ,Guinea-Bissau ,Clade ,Mozambique ,Migration ,Spoligotyping ,Molecular Epidemiology ,Bacterial Typing Techniques ,3. Good health ,Infectious Diseases ,language ,Brazil ,Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,030106 microbiology ,Biology ,Microbiology ,Article ,Mycobacterium tuberculosis ,03 medical and health sciences ,Genetics ,medicine ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,14. Life underwater ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Genetic diversity ,Portugal ,Public health ,Online database ,Genetic Variation ,Mycobacteria ,LAM ,medicine.disease ,biology.organism_classification ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,language.human_language ,030104 developmental biology ,Angola ,Drug resistance ,Portuguese ,Demography - Abstract
Tuberculosis (TB) remains a major health problem within the Community of Portuguese Language Speaking Countries (CPLP). Despite the marked variation in TB incidence across its member-states and continued human migratory flux between countries, a considerable gap in the knowledge on the Mycobacterium tuberculosis population structure and strain circulation between the countries still exists. To address this, we have assembled and analysed the largest CPLP M. tuberculosis molecular and drug susceptibility dataset, comprised by a total of 1447 clinical isolates, including 423 multidrug-resistant isolates, from five CPLP countries. The data herein presented reinforces Latin American and Mediterranean (LAM) strains as the hallmark of M. tuberculosis populational structure in the CPLP coupled with country-specific differential prevalence of minor clades. Moreover, using high-resolution typing by 24-loci MIRU-VNTR, six cross-border genetic clusters were detected, thus supporting recent clonal expansion across the Lusophone space. To make this data available to the scientific community and public health authorities we developed CPLP-TB (available at http://cplp-tb.ff.ulisboa.pt), an online database coupled with web-based tools for exploratory data analysis. As a public health tool, it is expected to contribute to improved knowledge on the M. tuberculosis population structure and strain circulation within the CPLP, thus supporting the risk assessment of strain-specific trends., Highlights • The Community of Portuguese Speaking Countries (CPLP) occupies a vast geographical area. • Three CPLP countries are shortlisted in the WHO's list of Top 30 high-burden countries. • Common Mycobacterium tuberculosis population structure denote historical strain flow. • Cross-border clusters suggest recent intercontinental tuberculosis transmission. • CPLP-TB: a novel strain database and framework for collaborative studies and strain tracing.
- Published
- 2019
- Full Text
- View/download PDF
32. An Overview of Research Priorities in Tuberculosis
- Author
-
Dennis Falzon, Matteo Zignol, Afranio Lineu Kritski, and Christian Lienhardt
- Subjects
Economic growth ,Antibiotic resistance ,Tuberculosis ,Emerging technologies ,medicine ,Disease ,Business ,medicine.disease ,World health - Abstract
Intensified research and innovation is one of the three pillars of the End-TB Strategy launched by the World Health Organization in 2015. This underscores the essentiality of research and development to reach the ambitious targets of reducing tuberculosis (TB) incidence and deaths by 80% and 90%, respectively, by the year 2030. The development of new technologies to diagnose, treat and prevent TB requires intensification of research along the full spectrum, from fundamental research for better understanding of human TB and discovery of novel diagnostics, drugs and vaccines, to implementation/operational research, for their introduction in clinical and programmatic practices, ensuring access to those in highest need. At time of increasing antibiotic resistance and emergence of new infectious diseases, investments in TB research will enhance the feasibility and accessibility of innovations to the populations most vulnerable to this disease, and continue to produce broad benefits to health that extend well beyond the fight against TB.
- Published
- 2021
- Full Text
- View/download PDF
33. Tuberculosis Burden and Determinants of Treatment Outcomes According to Age in Brazil: A Nationwide Ecological Study of 896,314 Cases Reported between 2010 and 2019
- Author
-
Moreno M. S. Rodrigues, Beatriz Barreto Duarte, Michael S. Rocha, Marcelo Cordeiro-Santos, Mariana Araújo-Pereira, Bruno B. Andrade, Luciana Sobral, Afranio Lineu Kritski, Artur T. L. Queiroz, María B. Arriaga, Alexandra B. Souza, Betania M. F. Nogueira, Vanessa Nascimento, and Timothy R. Sterling
- Subjects
education.field_of_study ,medicine.medical_specialty ,Tuberculosis ,business.industry ,Incidence (epidemiology) ,Public health ,Population ,Ecological study ,Logistic regression ,medicine.disease ,Acquired immunodeficiency syndrome (AIDS) ,Epidemiology ,medicine ,education ,business ,Demography - Abstract
Background: Approximately 1·4 million people die annually worldwide from tuberculosis. Large epidemiologic studies can identify determinants of unfavorable clinical outcomes according to age, which can guide implementation of public health policies and clinical management to improve outcomes. Methods: We obtained data from the national tuberculosis case registry: cases reported to the Brazilian National Program (SINAN) between 2010-2019. Clinical and epidemiologic variables were compared between age groups (child
- Published
- 2021
- Full Text
- View/download PDF
34. Pain perception and functional limitation, assessed in the years after nerve decompression in leprosy
- Author
-
Maria Kátia Gomes, Kazue Narahashi, Marcus André Acioly, Afranio Lineu Kritski, Felipe José Jandre dos Reis, Maria Dias Torres Kenedi, and Elifaz De Freitas Cabral
- Subjects
medicine.medical_specialty ,business.industry ,Physical therapy ,General Earth and Planetary Sciences ,Medicine ,Nerve decompression ,Pain perception ,Leprosy ,business ,medicine.disease ,General Environmental Science - Published
- 2018
- Full Text
- View/download PDF
35. The role of the Brazilian Tuberculosis Research Network in national and international efforts to eliminate tuberculosis
- Author
-
Afranio Lineu Kritski, Martha Maria Oliveira, Fernanda Carvalho de Queiroz Mello, Margareth Pretti Dalcolmo, Anna Cristina Calçada Carvalho, Julio Croda, and Denise Rossato Silva
- Subjects
Pulmonary and Respiratory Medicine ,Tuberculosis ,Biomedical Research ,030231 tropical medicine ,Human immunodeficiency virus (HIV) ,Public Policy ,Disease ,medicine.disease_cause ,Global Health ,World Health Organization ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,Global health ,Medicine ,Humans ,030212 general & internal medicine ,Disease Eradication ,Tuberculosis incidence ,Cause of death ,lcsh:RC705-779 ,business.industry ,lcsh:Diseases of the respiratory system ,medicine.disease ,Editorial ,Infectious disease (medical specialty) ,business ,Brazil - Abstract
In 2015, tuberculosis ranked as the leading cause of death from an infectious disease, surpassing HIV/AIDS.(1) In 2016, an estimated 10.4 million people developed tuberculosis and 1.7 million died from the disease, 5,000 people dying from it every day, including approximately 1,000 individuals with tuberculosis/HIV coinfection.(1) In the past decade, the global tuberculosis community has engaged in activities to successfully attain the Millennium Development Goal target and other international targets for halting and reversing increases in tuberculosis incidence and mortality.(1) However, despite the achievements made to date, the global incidence of tuberculosis is declining at a rate of only 1.5% per year, far from the 10% expected.
- Published
- 2018
36. A comparison of tuberculosis diagnostic systems in a retrospective cohort of HIV-infected children in Rio de Janeiro, Brazil
- Author
-
Maria de Fátima Bazhuni Pombo March, Clemax Couto Sant'Anna, Solange G. David, Afranio Lineu Kritski, Thalita G. Abreu, Antonio Ruffino Netto, and Kathryn L. Lovero
- Subjects
Microbiology (medical) ,Male ,Pediatrics ,medicine.medical_specialty ,Tuberculosis ,TB-HIV co-infection ,Adolescent ,HIV Infections ,Diagnostic system ,Sensitivity and Specificity ,Article ,lcsh:Infectious and parasitic diseases ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Hiv infected ,Medicine ,Humans ,lcsh:RC109-216 ,030212 general & internal medicine ,Medical diagnosis ,Diagnostic screening ,Child ,Tuberculosis, Pulmonary ,Retrospective Studies ,business.industry ,Coinfection ,Diagnostic Tests, Routine ,Gold standard ,Infant ,Retrospective cohort study ,TB–HIV co-infection ,General Medicine ,medicine.disease ,Pediatric TB ,Infectious Diseases ,030228 respiratory system ,Child, Preschool ,Cohort ,TB scoring systems ,Female ,business ,Brazil - Abstract
Summary Objectives The diagnosis of pediatric tuberculosis (TB) presents many challenges, and is further complicated in HIV-infected patients. While many diagnostic systems have been proposed, there is no pediatric TB diagnosis gold standard. The outcomes of four TB diagnostic systems in HIV-infected children were compared in this study. Methods A retrospective cohort study was conducted at a TB/HIV reference hospital in Rio de Janeiro. HIV-infected pediatric patients evaluated for TB from 1998 to 2010 were reassessed using four diagnostic systems: Kenneth Jones, 1969; Tidjani, 1986; Ben Marais, 2006; Brazilian Ministry of Health, 2010. Results were compared to standardized diagnoses made by an expert panel of physicians. Results Of the 121 patients in the study cohort, the expert panel diagnosed 64 as TB and 57 as not TB cases. The Tidjani system showed the highest diagnostic accuracy, with and without the inclusion of microbiological data. The Tidjani and Kenneth Jones systems produced fewer false-positives, and the Ben Marais and Ministry of Health fewer false-negatives. Across systems, there was little agreement between TB diagnoses. Conclusions In HIV-infected pediatric patients, the Ben Marais and Ministry of Health systems are useful for TB diagnostic screening, whereas the Tidjani and Kenneth Jones systems are best used in a reference center setting.
- Published
- 2017
37. Evaluation of pulmonary tuberculosis diagnostic tests in children and adolescents at a pediatric reference center
- Author
-
Andrea Maciel de Oliveira Rossoni, Kathryn L. Lovero, Marssoni Deconto Rossoni, Antonio Ruffino Netto, Elisangela A.S. Lizzi, Afranio Lineu Kritski, Tonny T. Tahan, Isabela Neves de Almeida, and Cristina de Oliveira Rodrigues
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Scoring system ,Tuberculosis ,Adolescent ,Tuberculin ,Article ,ADOLESCENTES ,Clinical study ,03 medical and health sciences ,0302 clinical medicine ,Pulmonary tuberculosis ,Predictive Value of Tests ,Internal medicine ,Diagnosis ,Medicine ,Pediatric hospital ,Humans ,030212 general & internal medicine ,Child ,Tuberculosis, Pulmonary ,business.industry ,Diagnostic Tests, Routine ,Tuberculin Test ,Diagnostic test ,Gold standard (test) ,Skin test ,medicine.disease ,030228 respiratory system ,Lung disease ,business - Abstract
Introduction This study evaluates the performance of individual and combinations tests used for pediatric tuberculosis diagnosis at a reference center. Materials and Methods Diagnostic test outcomes from children with presumed pulmonary tuberculosis evaluated from January 2005 - July 2010 were compared to a standard diagnosis made by an expert panel of physicians. Results Presence of at least one sign/symptom, history of contact, or abnormal chest X-ray (aCXR) individually showed the highest sensitivity (85.7%). While the combination of history of contact, at least one sign/symptom, positive tuberculin skin test, and aCXR had low sensitivity of 20%, but the specificity and a positive predictive value were 100%, respectively. The combination of tests used in the International Union Against Tuberculosis and Lung Disease and the Brazilian Ministry of Health systems showed sensitivity of 28.6% and 71.4% and specificity of 95.8% and 97.0%, respectively. Conclusions In the absence of a gold standard, the combination of clinical history, tuberculin skin test, and aCXR, as well as the Brazilian scoring system serve as simple, low-cost approach that can be used for pediatric TB diagnosis by first-contact care providers.
- Published
- 2020
38. Factors associated with non-completion of latent tuberculosis infection treatment in Rio de Janeiro, Brazil: A non-matched case control study
- Author
-
R.M. de Aguiar, M.A.M. da Silva Vieira, Antonio Ruffino-Netto, Anna Cristina Calçada Carvalho, I. N. de Almeida, D.M. de Paula Ramalho, and Afranio Lineu Kritski
- Subjects
Pulmonary and Respiratory Medicine ,Drug ,medicine.medical_specialty ,Tuberculosis ,Multivariate analysis ,media_common.quotation_subject ,Drug intolerance ,03 medical and health sciences ,0302 clinical medicine ,Latent Tuberculosis ,Risk Factors ,Internal medicine ,Medicine ,Humans ,030212 general & internal medicine ,Index case ,media_common ,Latent tuberculosis ,business.industry ,DOENÇA PULMONAR (ESPECIALIDADE) ,Case-control study ,Non completion ,medicine.disease ,030228 respiratory system ,Case-Control Studies ,business ,Brazil - Abstract
Introduction There are scarce data on the routine latent tuberculosis infection treatment (LTBIT) and factors associated with a non-completion in high tuberculosis burden countries. Therefore, in this study we aimed to evaluate the factors associated with non-completion of LTBIT. Materials and methods This was a non-matched case control study conducted at a University Hospital in Rio de Janeiro, Brazil. A total of 114 cases and 404 controls were enrolled between January/1999 and December/2009. Cases were close contacts who did not complete the LTBIT and controls were the contacts that completed it. Multivariate analysis was used to investigate risk factors associated with non-completion of LTBIT among contacts in two different periods of recruitment. Results Factors associated with non-completion LTBIT included: drug use (OR 23.33, 95% CI 1.83–296.1), TB treatment default by the index case (OR 16.97, 95% CI 3.63–79.24) and drug intolerance. TB disease rates after two years of follow up varied from 0.4% to 1.9%. The number necessary to treat to prevent one TB case among contacts was 116. Conclusions Non-completion treatment by the index case and illicit drug use were associated with not completing latent tuberculosis infection treatment and no tuberculosis disease was identified among those who completed latent tuberculosis infection treatment.
- Published
- 2019
39. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis
- Author
-
Timothy R Sterling, Afranio Lineu Kritski, María B. Arriaga, Bruno B. Andrade, Peter F Rebeiro, Solange Calvacante, Marina C. Figueiredo, Megan Turner, Lauren S Peetluk, Betina Durovni, Valeria Cavalcanti Rolla, and Marcelo Cordeiro-Santos
- Subjects
0301 basic medicine ,Adult ,Male ,medicine.medical_specialty ,Tuberculosis ,Time Factors ,030106 microbiology ,Antitubercular Agents ,Weight Gain ,03 medical and health sciences ,Major Articles and Brief Reports ,0302 clinical medicine ,Internal medicine ,HIV Seropositivity ,Isoniazid ,Immunology and Allergy ,Medicine ,Humans ,030212 general & internal medicine ,Prospective Studies ,Tuberculosis, Pulmonary ,Ethambutol ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Weight change ,Hazard ratio ,Pyrazinamide ,Middle Aged ,medicine.disease ,Confidence interval ,Infectious Diseases ,Treatment Outcome ,Female ,medicine.symptom ,Rifampin ,business ,Weight gain ,Brazil ,medicine.drug - Abstract
Background Weight change may inform tuberculosis treatment response, but its predictive power may be confounded by human immunodeficiency virus (HIV). Methods We prospectively followed up adults with culture-confirmed, drug-susceptible, pulmonary tuberculosis receiving standard 4-drug therapy (isoniazid, rifampin, pyrazinamide, and ethambutol) in Brazil. We examined median weight change 2 months after treatment initiation by HIV status, using quantile regression, and unsuccessful tuberculosis treatment outcome (treatment failure, tuberculosis recurrence, or death) by HIV and weight change status, using Cox regression. Results Among 547 participants, 102 (19%) were HIV positive, and 35 (6%) had an unsuccessful outcome. After adjustment for confounders, persons living with HIV (PLWH) gained a median of 1.3 kg (95% confidence interval [CI], −2.8 to .1) less than HIV-negative individuals during the first 2 months of tuberculosis treatment. PLWH were at increased risk of an unsuccessful outcome (adjusted hazard ratio, 4.8; 95% CI, 2.1–10.9). Weight change was independently associated with outcome, with risk of unsuccessful outcome decreasing by 12% (95% CI, .81%–.95%) per 1-kg increase. Conclusions PLWH gained less weight during the first 2 months of tuberculosis treatment, and lack of weight gain and HIV independently predicted unsuccessful tuberculosis treatment outcomes. Weight, an easily collected biomarker, may identify patients who would benefit from alternative treatment strategies.
- Published
- 2019
40. Serological biomarkers for monitoring response to treatment of pulmonary and extrapulmonary tuberculosis in children and adolescents
- Author
-
Maria de Fátima Bazhuni Pombo March, Thais Raquelly Dourado de Oliveira, Luis Guillermo Coca Velarde, Ana Paula Barbosa, Adriano Queiroz, Ana Cláudia Mamede Wiering de Barros, Clemax C. SantÀAnna, Julienne Martins Araujo, Christiane Mello Schmidt, Kathryn L. Lovero, Lee W. Riley, Ana Paula Quintanilha, Estela Magalhães Cosme, Ana Lúcia Miceli, Sheila Moura Pone, Camila de Paula Martins, Danielle C.M. dos Santos, Afranio Lineu Kritski, Claudete Aparecida Araújo Cardoso, Marcos Vinicius da Silva Pone, Maria Luíza Vieira, and Selma Maria de Azevedo Sias
- Subjects
0301 basic medicine ,Male ,Time Factors ,Immunoglobulin levels ,Antitubercular Agents ,Mycolic acid ,Prospective Studies ,Child ,chemistry.chemical_classification ,biology ,Age Factors ,Response to treatment ,Infectious Diseases ,Treatment Outcome ,Mycolic Acids ,Serological biomarkers ,Child, Preschool ,Female ,Drug Monitoring ,Microbiology (medical) ,medicine.medical_specialty ,Tuberculosis ,Adolescent ,Cardiolipins ,030106 microbiology ,Immunology ,Enzyme-Linked Immunosorbent Assay ,Microbiology ,Article ,Mycobacterium tuberculosis ,03 medical and health sciences ,Antigens present ,Bacterial Proteins ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,Tuberculosis, Pulmonary ,Sulfoglycosphingolipids ,business.industry ,Extrapulmonary tuberculosis ,Infant ,biology.organism_classification ,medicine.disease ,030104 developmental biology ,chemistry ,Immunoglobulin M ,Case-Control Studies ,Immunoglobulin G ,business ,Biomarkers - Abstract
Key measures to halt the spread of tuberculosis (TB) include early diagnosis, effective treatment, and monitoring disease management. We sought to evaluate the use of serum immunoglobulin levels against antigens present in cell envelope of Mycobacterium tuberculosis to monitor TB treatment response in children and adolescents with pulmonary (PTB) or extrapulmonary TB (EPTB). Blood samples were collected prior to and one, two, and six months following treatment initiation. Serum immunoglobulin levels against cardiolipin, sulfatide, mycolic acid and Mce1A protein were measured by ELISA. Serum from 53 TB patients and 12 healthy participants were analyzed. After six months of successful treatment, there was a significant decrease (p 0.0001) in IgM levels against cardiolipin, sulfatide, mycolic acid and Mce1A protein and IgG levels against Mce1A protein when compared to baseline immunoglobulin levels. There was no significant variation in antibody levels during follow-up between participants with PTB and EPTB, confirmed and unconfirmed TB diagnosis, and HIV infection status. Antibody levels in control participants without TB did not decrease during follow-up. These results suggest that immunoglobulin responses to mycobacterial cell wall products may be a useful tool to monitor treatment response in children and adolescents with PTB or EPTB.
- Published
- 2019
41. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil
- Author
-
E. R. Dalla Costa, Afranio Lineu Kritski, I. N. de Almeida, I. S. Anusca, B. M. Praetzel, Gisela Unis, Sun Hee Schiefelbein, Regina Bones Barcellos, L. J. de Assis Figueredo, R. S. Salvato, Maria Laura Halon, Silvana Spíndola de Miranda, Leonardo Souza Esteves, Claudia Fontoura Dias, Maria Lucia Rosa Rossetti, and Elisangela C. Silva
- Subjects
0301 basic medicine ,Adult ,Male ,Tuberculosis ,Adolescent ,Databases, Factual ,Genotype ,Epidemiology ,tuberculosis (TB) ,030106 microbiology ,Antitubercular Agents ,Drug resistance ,Microbial Sensitivity Tests ,Minisatellite Repeats ,Biology ,Risk Assessment ,Mycobacterium tuberculosis ,03 medical and health sciences ,Young Adult ,Age Distribution ,Bacterial Proteins ,Cost of Illness ,Drug Resistance, Multiple, Bacterial ,Tuberculosis, Multidrug-Resistant ,medicine ,Humans ,Multidrug-Resistant Mycobacterium tuberculosis ,Sex Distribution ,Genotyping ,Retrospective Studies ,Original Paper ,drug resistance ,INHA ,Incidence ,DNA-Directed RNA Polymerases ,Middle Aged ,rpoB ,medicine.disease ,biology.organism_classification ,bacterial infections and mycoses ,Virology ,030104 developmental biology ,Infectious Diseases ,genotyping ,Female ,Rifampicin ,Brazil ,medicine.drug - Abstract
Tuberculosis (TB) is the leading cause of death among infectious diseases worldwide. Among the estimated cases of drug-resistant TB, approximately 60% occur in the BRICS countries (Brazil, Russia, India, China and South Africa). Among Brazilian states, primary and acquired multidrug-resistant TB (MDR-TB) rates were the highest in Rio Grande do Sul (RS). This study aimed to perform molecular characterisation of MDR-TB in the State of RS, a high-burden Brazilian state. We performed molecular characterisation of MDR-TB cases in RS, defined by drug susceptibility testing, using 131Mycobacterium tuberculosis (M.tb)DNA samples from the Central Laboratory. We carried out MIRU-VNTR 24loci, spoligotyping, sequencing of thekatG,inhA andrpoB genes and RDRiosublineage identification. The most frequent families found were LAM (65.6%) and Haarlem (22.1%). RDRiodeletion was observed in 42 (32%) of theM.tbisolates. Among MDR-TB cases, eight (6.1%) did not present mutations in the studied genes. In 116 (88.5%)M.tbisolates, we found mutations associated with rifampicin (RIF) resistance inrpoB gene, and in 112 isolates (85.5%), we observed mutations related to isoniazid resistance inkatG andinhA genes. An insertion of 12 nucleotides (CCAGAACAACCC) at the 516 codon in therpoB gene, possibly responsible for a decreased interaction of RIF and RNA polymerase, was found in 19/131 of the isolates, belonging mostly to LAM and Haarlem families. These results enable a better understanding of the dynamics of transmission and evolution of MDR-TB in the region.
- Published
- 2019
42. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy
- Author
-
Martha Maria Oliveira, María B. Arriaga, Bruno B. Andrade, Anneloek Rauwerdink, Paulo S. Silveira-Mattos, Afranio Lineu Kritski, Leonardo Gil-Santana, Luís A. B. Cruz, Eliene Denites Duarte Mesquita, Frank Cobelens, Kiyoshi F. Fukutani, Marina G. Oliveira, Pryscila Miranda, Elisangela C. Silva, Graduate School, Radiology and Nuclear Medicine, Other Research, Global Health, AII - Infectious diseases, APH - Global Health, APH - Methodology, and APH - Quality of Care
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Tuberculosis ,Anemia ,Antitubercular Agents ,lcsh:Medicine ,Inflammation ,Systemic inflammation ,Gastroenterology ,Statistics, Nonparametric ,Article ,Young Adult ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Young adult ,lcsh:Science ,Multidisciplinary ,medicine.diagnostic_test ,business.industry ,lcsh:R ,Middle Aged ,medicine.disease ,3. Good health ,030104 developmental biology ,chemistry ,Erythrocyte sedimentation rate ,Sputum ,Uric acid ,lcsh:Q ,Female ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Pulmonary tuberculosis (PTB) is associated with chronic inflammation and anemia. How anemia impacts systemic inflammation in PTB patients undergoing antitubercular therapy (ATT) is not fully understood. In the present study, data on several blood biochemical parameters were retrospectively analyzed from 118 PTB patients during the first 60 days of ATT. Multidimensional statistical analyses were employed to perform detailed inflammatory profiling of patients stratified by anemia status prior to treatment. Anemia was defined as hemoglobin levels
- Published
- 2019
- Full Text
- View/download PDF
43. Corrigendum to 'Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents' [Tuberculosis 120 (2020) 101893]
- Author
-
Kathryn L. Lovero, Ana Paula Barbosa, Lee W. Riley, Ana Cláudia Mamede Wiering de Barros, Andrea Alice da Silva, Afranio Lineu Kritski, Maria Luíza Vieira, Danielle C.M. dos Santos, Adriano Queiroz, Luis Guillermo Coca Velarde, Sheila Moura Pone, Camila de Paula Martins, Clemax Couto Sant'Anna, Ana Paula Quintanilha, Julienne Martins Araujo, Selma Maria de Azevedo Sias, Ana Lúcia Miceli, Solange G.D. Macedo, Christiane Mello Schmidt, Fabiana Rabe Carvalho, Claudete Aparecida Araújo Cardoso, and Marcos Vinicius da Silva Pone
- Subjects
Microbiology (medical) ,Tuberculosis ,biology ,Latent tuberculosis ,business.industry ,Immunology ,medicine.disease ,Microbiology ,Infectious Diseases ,biology.protein ,Medicine ,Differential diagnosis ,Antibody ,business - Published
- 2021
- Full Text
- View/download PDF
44. Beyond goodwill and promises—urgent needs and opportunities to accelerate the fight against tuberculosis in Brazil
- Author
-
Carlos Podalirio Borges de Almeida, Anete Trajman, Carole Diane Mitnick, Afrânio Lineu Kritski, and Ezio Távora dos Santos-Filho
- Subjects
Public aspects of medicine ,RA1-1270 - Published
- 2024
- Full Text
- View/download PDF
45. A screening system for smear-negative pulmonary tuberculosis using artificial neural networks
- Author
-
Basilio de Bragança Pereira, João Baptista de Oliveira e Souza Filho, Afranio Lineu Kritski, Rafael Mello Galliez, Alcione Miranda dos Santos, José Manoel de Seixas, and Fernanda Carvalho de Queiroz Mello
- Subjects
Adult ,Male ,Cart ,Microbiology (medical) ,medicine.medical_specialty ,030231 tropical medicine ,Decision support systems ,Logistic regression ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Pulmonary tuberculosis ,Internal medicine ,medicine ,Humans ,Mass Screening ,lcsh:RC109-216 ,030212 general & internal medicine ,Tuberculosis, Pulmonary ,Data mining ,Computational intelligence ,Artificial neural network ,Receiver operating characteristic ,business.industry ,Mycobacterium tuberculosis ,General Medicine ,Middle Aged ,Confidence interval ,Logistic Models ,Infectious Diseases ,ROC Curve ,Multilayer perceptron ,Female ,Neural Networks, Computer ,business ,Risk assessment - Abstract
Summary Objectives Molecular tests show low sensitivity for smear-negative pulmonary tuberculosis (PTB). A screening and risk assessment system for smear-negative PTB using artificial neural networks (ANNs) based on patient signs and symptoms is proposed. Methods The prognostic and risk assessment models exploit a multilayer perceptron (MLP) and inspired adaptive resonance theory (iART) network. Model development considered data from 136 patients with suspected smear-negative PTB in a general hospital. Results MLP showed higher sensitivity (100%, 95% confidence interval (CI) 78–100%) than the other techniques, such as support vector machine (SVM) linear (86%; 95% CI 60–96%), multivariate logistic regression (MLR) (79%; 95% CI 53–93%), and classification and regression tree (CART) (71%; 95% CI 45–88%). MLR showed a slightly higher specificity (85%; 95% CI 59–96%) than MLP (80%; 95% CI 54–93%), SVM linear (75%, 95% CI 49–90%), and CART (65%; 95% CI 39–84%). In terms of the area under the receiver operating characteristic curve (AUC), the MLP model exhibited a higher value (0.918, 95% CI 0.824–1.000) than the SVM linear (0.796, 95% CI 0.651–0.970) and MLR (0.782, 95% CI 0.663–0.960) models. The significant signs and symptoms identified in risk groups are coherent with clinical practice. Conclusions In settings with a high prevalence of smear-negative PTB, the system can be useful for screening and also to aid clinical practice in expediting complementary tests for higher risk patients.
- Published
- 2016
- Full Text
- View/download PDF
46. Brazilian Response to Global End TB Strategy : The National Tuberculosis Research Agenda
- Author
-
Afranio Lineu Kritski, Martha Maria Oliveira, Teresa Cristina Scatena Villa, Draurio Barreira, Inacio Queiroz, Ethel Leonor Noia Maciel, Maria do Socorro Nantua Evangelista, Fernanda Dockhorn Costa, Mauro Niskier Sanchez, Marco Aurélio Krieger, José Roberto Lapa e Silva, Ana Paula Junqueira-Kipnis, Maria M. Campos, Ruy Souza Junior, Wim Mauritz Degrave, Erica Chimara, Margareth Pretti Dalcolmo, Carlos M. Morel, Silvana Spíndola de Miranda, Milton Ozório Moraes, and Antonio Ruffino-Netto
- Subjects
Microbiology (medical) ,Economic growth ,lcsh:Arctic medicine. Tropical medicine ,Biomedical Research ,Tuberculosis ,National Health Programs ,lcsh:RC955-962 ,Health Priorities ,business.industry ,International Cooperation ,030231 tropical medicine ,Global Health ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,030228 respiratory system ,POLÍTICA DE SAÚDE ,Humans ,Medicine ,Parasitology ,business ,Brazil - Published
- 2016
- Full Text
- View/download PDF
47. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
- Author
-
Parvaneh Baghaei, Nicolas Veziris, Nesri Padayatchi, Anete Trajman, Timothy H. Holtz, Ying Cai, Janice Westenhouse, Ignacio Monedero, Sarah Smith, Vija Riekstina, Dick Menzies, Maria I. Rodriguez, Payam Tabarsi, Lia D'Ambrosio, Maia Kipiani, Didi Bang, Norbert Ndjeka, Suzanne M. Marks, Maryline Bonnet, Medea Gegia, Jan-Willem C. Alffenaar, James C.M. Brust, Ethel Leonor Noia Maciel, Zarir F Udwadia, Tae Sun Shim, Phil Lowenthal, Lorenzo Guglielmetti, Domingo Palmero, Carole D. Mitnick, Chi-Chiu Leung, Gerard de Vries, Shama D. Ahuja, Faiz Ahmad Khan, Sue Gu, Rafael Laniado-Laborín, Lawrence Mbuagbaw, Nakwon Kwak, Margareth Pretti Dalcolmo, Russell R. Kempker, Erika Mohr, Christoph Lange, Kathleen F. Walsh, Serena P. Koenig, Vladimir Milanov, Sundari Mase, Liga Kuksa, Tjip S. van der Werf, Kwok-Chiu Chang, Mayara Lisboa Bastos, Andrea Benedetti, Payam Nahid, Gregory P. Bisson, Geisa Fregona, Zhiyi Lan, Simon Tiberi, Won-Jung Koh, Eric Caumes, Jennifer Hughes, Maria Tarcela Gler, Keertan Dheda, Martin J. Boeree, Piret Viiklepp, Macarthur Charles, Nicola M. Zetola, Chawangwa Modongo, Barbara Seaworth, Eric Chung Ching Leung, Kathryn Schnippel, Ann C. Miller, Giovanni Battista Migliori, J. Peter Cegielski, Matteo Zignol, Kwonjune J. Seung, Digamber Behera, Salmaan Keshavjee, Laura F Anderson, Nafees Ahmad, Jérôme Robert, Afranio Lineu Kritski, Wing Wai Yew, Rupak Singla, Aliasgar Esmail, Mathilde Fréchet-Jachym, Ganzaya Sukhbaatar, Onno W. Akkerman, Rosella Centis, Stalz Charles Vilbrun, Pei-Chun Chan, Laura Jean Podewils, Edward D. Chan, Pei Zhi Li, Leah G. Jarlsberg, Sarah K. Brode, Charlotte Kvasnovsky, Jean W. Pape, Gregory J. Fox, Lisa Trieu, Ian R Reynolds, Petros Isaakidis, Pennan M. Barry, Vaira Leimane, Max R. O'Donnell, Andra Cirule, Myungsun Lee, Jae-Joon Yim, Giovanni Sotgiu, Jennifer Flood, Regina Gayoso, and Microbes in Health and Disease (MHD)
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Tuberculosis ,030106 microbiology ,COHORT ANALYSIS ,REGIMENS ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Pharmacotherapy ,Moxifloxacin ,Internal medicine ,HIGH-RATES ,medicine ,MANAGEMENT ,030212 general & internal medicine ,XDR-TB ,DRUG-RESISTANCE ,business.industry ,Absolute risk reduction ,General Medicine ,Odds ratio ,medicine.disease ,SOUTH-AFRICA ,BEDAQUILINE ,LINEZOLID TREATMENT ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,chemistry ,Meta-analysis ,SAFETY ,Bedaquiline ,business ,medicine.drug ,Cohort study - Abstract
Item does not contain fulltext BACKGROUND: Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis. METHODS: In this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane Library to identify potentially eligible observational and experimental studies published between Jan 1, 2009, and April 30, 2016. We also searched reference lists from all systematic reviews of treatment of multidrug-resistant tuberculosis published since 2009. To be eligible, studies had to report original results, with end of treatment outcomes (treatment completion [success], failure, or relapse) in cohorts of at least 25 adults (aged >18 years). We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics, treatment, and outcomes. Using propensity score-matched generalised mixed effects logistic, or linear regression, we calculated adjusted odds ratios and adjusted risk differences for success or death during treatment, for specific drugs currently used to treat multidrug-resistant tuberculosis, as well as the number of drugs used and treatment duration. FINDINGS: Of 12 030 patients from 25 countries in 50 studies, 7346 (61%) had treatment success, 1017 (8%) had failure or relapse, and 1729 (14%) died. Compared with failure or relapse, treatment success was positively associated with the use of linezolid (adjusted risk difference 0.15, 95% CI 0.11 to 0.18), levofloxacin (0.15, 0.13 to 0.18), carbapenems (0.14, 0.06 to 0.21), moxifloxacin (0.11, 0.08 to 0.14), bedaquiline (0.10, 0.05 to 0.14), and clofazimine (0.06, 0.01 to 0.10). There was a significant association between reduced mortality and use of linezolid (-0.20, -0.23 to -0.16), levofloxacin (-0.06, -0.09 to -0.04), moxifloxacin (-0.07, -0.10 to -0.04), or bedaquiline (-0.14, -0.19 to -0.10). Compared with regimens without any injectable drug, amikacin provided modest benefits, but kanamycin and capreomycin were associated with worse outcomes. The remaining drugs were associated with slight or no improvements in outcomes. Treatment outcomes were significantly worse for most drugs if they were used despite in-vitro resistance. The optimal number of effective drugs seemed to be five in the initial phase, and four in the continuation phase. In these adjusted analyses, heterogeneity, based on a simulated I(2) method, was high for approximately half the estimates for specific drugs, although relatively low for number of drugs and durations analyses. INTERPRETATION: Although inferences are limited by the observational nature of these data, treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis. These findings emphasise the need for trials to ascertain the optimal combination and duration of these drugs for treatment of this condition. FUNDING: American Thoracic Society, Canadian Institutes of Health Research, US Centers for Disease Control and Prevention, European Respiratory Society, Infectious Diseases Society of America.
- Published
- 2018
48. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
- Author
-
Melinda Munang, Rafael Mello Galliez, Viet Nhung Nguyen, Jung-Yien Chien, Takashi Yoshiyama, Dick Menzies, Anthony J. Garcia-Prats, Won-Jung Koh, Peter Cegielski, Afranio Lineu Kritski, Onno W. Akkerman, Payam Tabarsi, Patrick P. J. Phillips, Mayara Lisboa Bastos, Piret Viiklepp, Parvaneh Baghaei, James C. Johnston, Andrea Benedetti, Stephen H. Gillespie, Medea Gegia, Judith R. Glynn, Martin Dedicoat, Corinne Merle, Randall Reves, Kwonjune J. Seung, Jong Sun Park, Edward C. Jones-López, Alena Skrahina, Awal Khan, Connie Erkens, Ethel Leonor Noia Maciel, Kamila Romanowski, Jann-Yuan Wang, Dick van Soolingen, Shama D. Ahuja, Stefan V. Goldberg, C Ponnuraja, Patricio Escalante, Velayutham V. Banurekha, Helen Cox, Anete Trajman, Jae Ho Lee, Akihiro Ohkado, Federica Fregonese, David E. Griffith, Pei Zhi Li, Dennis Falzon, Irene Ayakaka, Lisa Trieu, Zhi Yi Lan, Didi Bang, G. Narendran, H. Simon Schaaf, Denise Arakaki-Sanchez, Karen R. Jacobson, Adithya Cattamanchi, Andrew J. Nunn, Maryline Bonnet, Microbes in Health and Disease (MHD), University of St Andrews. School of Medicine, University of St Andrews. Infection and Global Health Division, University of St Andrews. Global Health Implementation Group, University of St Andrews. Gillespie Group, University of St Andrews. Biomedical Sciences Research Complex, and University of St Andrews. Infection Group
- Subjects
0301 basic medicine ,Outcome Assessment ,Antitubercular Agents ,RELAPSE ,3rd-NDAS ,Cohort Studies ,0302 clinical medicine ,RA0421 ,Antibiotics ,RA0421 Public health. Hygiene. Preventive Medicine ,Outcome Assessment, Health Care ,Tuberculosis, Multidrug-Resistant ,polycyclic compounds ,030212 general & internal medicine ,Lung ,Randomized Controlled Trials as Topic ,Multidrug-Resistant ,Observational Studies as Topic ,6.1 Pharmaceuticals ,Combination ,Streptomycin ,Public Health and Health Services ,Drug Therapy, Combination ,MYCOBACTERIUM-TUBERCULOSIS ,Rifampin ,Infection ,Ethambutol ,medicine.drug ,Cohort study ,Fluoroquinolones ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Tuberculosis ,REGIMEN ,PULMONARY TUBERCULOSIS ,030106 microbiology ,Clinical Trials and Supportive Activities ,Clinical Sciences ,RETREATMENT ,Antitubercular ,Article ,Drug Administration Schedule ,CLINICAL-TRIAL ,03 medical and health sciences ,Rare Diseases ,SDG 3 - Good Health and Well-being ,Drug Therapy ,Clinical Research ,Internal medicine ,medicine ,Isoniazid ,Humans ,Antibiotics, Antitubercular ,Tuberculosis, Pulmonary ,DRUG-RESISTANCE ,Other Medical and Health Sciences ,business.industry ,MUTATIONS ,Evaluation of treatments and therapeutic interventions ,Odds ratio ,Mycobacterium tuberculosis ,Pyrazinamide ,bacterial infections and mycoses ,medicine.disease ,EFFICACY ,Clinical trial ,Health Care ,Regimen ,Review Literature as Topic ,Good Health and Well Being ,Antimicrobial Resistance ,TREATMENT OUTCOMES ,business ,Rifampicin - Abstract
Funding: World Health Organization and Canadian Institutes of Health Research. Background: Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acquired rifampicin resistance if treated with first-line anti-tuberculosis drugs. The aim of the study was to compare success, mortality, and acquired rifampicin resistance in patients with INH-R pulmonary tuberculosis given different durations of rifampicin, ethambutol, and pyrazinamide (REZ); a fluoroquinolone plus 6 months or more of REZ; and streptomycin plus a core regimen of REZ. Methods: Studies with regimens and outcomes known for individual patients with INH-R tuberculosis were eligible, irrespective of the number of patients if randomised trials, or with at least 20 participants if a cohort study. Studies were identified from two relevant systematic reviews, an updated search of one of the systematic reviews (for papers published between April 1, 2015, and Feb 10, 2016), and personal communications. Individual patient data were obtained from authors of eligible studies. The individual patient data meta-analysis was performed with propensity score matched logistic regression to estimate adjusted odds ratios (aOR) and risk differences of treatment success (cure or treatment completion), death during treatment, and acquired rifampicin resistance. Outcomes were measured across different treatment regimens to assess the effects of: different durations of REZ (≤6 months vs >6 months); addition of a fluoroquinolone to REZ (fluoroquinolone plus 6 months or more of REZ vs 6 months or more of REZ); and addition of streptomycin to REZ (streptomycin plus 6 months of rifampicin and ethambutol and 1–3 months of pyrazinamide vs 6 months or more of REZ). The overall quality of the evidence was assessed using GRADE methodology. Findings: Individual patient data were requested for 57 cohort studies and 17 randomised trials including 8089 patients with INH-R tuberculosis. We received 33 datasets with 6424 patients, of which 3923 patients in 23 studies received regimens related to the study objectives. Compared with a daily regimen of 6 months of (H)REZ (REZ with or without isoniazid), extending the duration to 8–9 months had similar outcomes; as such, 6 months or more of (H)REZ was used for subsequent comparisons. Addition of a fluoroquinolone to 6 months or more of (H)REZ was associated with significantly greater treatment success (aOR 2·8, 95% CI 1·1–7·3), but no significant effect on mortality (aOR 0·7, 0·4–1·1) or acquired rifampicin resistance (aOR 0·1, 0·0–1·2). Compared with 6 months or more of (H)REZ, the standardised retreatment regimen (2 months of streptomycin, 3 months of pyrazinamide, and 8 months of isoniazid, rifampicin, and ethambutol) was associated with significantly worse treatment success (aOR 0·4, 0·2–0·7). The quality of the evidence was very low for all outcomes and treatment regimens assessed, owing to the observational nature of most of the data, the diverse settings, and the imprecision of estimates. Interpretation: In patients with INH-R tuberculosis, compared with treatment with at least 6 months of daily REZ, addition of a fluoroquinolone was associated with better treatment success, whereas addition of streptomycin was associated with less treatment success; however, the quality of the evidence was very low. These results support the conduct of randomised trials to identify the optimum regimen for this important and common form of drug-resistant tuberculosis. Funding World Health Organization and Canadian Institutes of Health Research. Postprint
- Published
- 2018
49. REDbox: a comprehensive semantic framework for data collection and management in tuberculosis research
- Author
-
Vinícius Costa Lima, Rui Pedro Charters Lopes Rijo, Filipe Andrade Bernardi, Márcio Eloi Colombo Filho, Francisco Barbosa-Junior, Felipe Carvalho Pellison, Rafael Mello Galliez, Afrânio Lineu Kritski, and Domingos Alves
- Subjects
Medicine ,Science - Abstract
Abstract Clinical research outcomes depend on the correct definition of the research protocol, the data collection strategy, and the data management plan. Furthermore, researchers often need to work within challenging contexts, as is the case in tuberculosis services, where human and technological resources for research may be scarce. Electronic Data Capture Systems mitigate such risks and enable a reliable environment to conduct health research and promote result dissemination and data reusability. The proposed solution is based on needs pinpointed by researchers, considering the need for an accommodating solution to conduct research in low-resource environments. The REDbox framework was developed to facilitate data collection, management, sharing, and availability in tuberculosis research and improve the user experience through user-friendly, web-based tools. REDbox combines elements of the REDCap and KoBoToolbox electronic data capture systems and semantics to deliver new valuable tools that meet the needs of tuberculosis researchers in Brazil. The framework was implemented in five cross-institutional, nationwide projects to evaluate the users' perceptions of the system's usefulness and the information and user experience. Seventeen responses (representing 40% of active users) to an anonymous survey distributed to active users indicated that REDbox was perceived to be helpful for the particular audience of researchers and health professionals. The relevance of this article lies in the innovative approach to supporting tuberculosis research by combining existing technologies and tailoring supporting features.
- Published
- 2023
- Full Text
- View/download PDF
50. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2—The results of ProBCG: a multicenter randomized clinical trial in Brazil
- Author
-
Ana Paula Santos, Guilherme Loureiro Werneck, Ana Paula Razal Dalvi, Carla Conceição dos Santos, Paulo Fernando Guimarães Morando Marzocchi Tierno, Hanna Silva Condelo, Bruna Macedo, Janaina Aparecida de Medeiros Leung, Jeane de Souza Nogueira, Ludmila Malvão, Rafael Galliez, Roberta Aguiar, Roberto Stefan, Sabrina Modena Knackfuss, Elisangela Costa da Silva, Terezinha Marta Pereira Pinto Castineiras, Roberto de Andrade Medronho, José Roberto Lapa e Silva, Rogério Lopes Rufino Alves, Luís Cristóvão de Moraes Sobrino Porto, Luciana Silva Rodrigues, Afrânio Lineu Kritski, and Fernanda Carvalho de Queiroz Mello
- Subjects
COVID-19 ,BCG ,Vaccine ,Infectious and parasitic diseases ,RC109-216 - Abstract
ABSTRACT: Objectives: Evatuate if Bacillus Calmette-Guérin (BCG) vaccine could be used as a tool against SARS-CoV-2 based on the concept of trained immunity. Methods: A multicenter, double-blinded, randomized clinical trial recruited health care workers (HCWs) in Brazil. The incidence rates of COVID-19, clinical manifestations, absenteeism, and adverse events among HCWs receiving BCG vaccine (Moreau or Moscow strains) or placebo were compared. BCG vaccine-mediated immune response before and after implementing specific vaccines for COVID-19 (CoronaVac or COVISHIELD) was analyzed. Cox proportional hazard and linear mixed effect modeling were used. Results: A total of 264 volunteers were included for analysis (BCG = 134 and placebo = 130). The placebo group presented a COVID-19 cumulative incidence of 0.75% vs 0.52% of BCG. The Moreau strain also presented a higher incidence rate (1.60% × 0.22%). BCG did not show a protective hazard ratio against COVID-19. In addition, the log (immunoglobulin G) level against SARS-CoV-2 presented a higher increase in the BCG group, whether or not participants had COVID-19, but also without statistical significance. Conclusion: Our results suggest that BCG has a tendency of protection against SARS-CoV-2 and higher immunoglobulin G levels than placebo. The clinical trial was registered at https://clinicaltrials.gov/ (NCT04659941).
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.